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Abstract 
The present study investigates the role of Phosphoinositide 3 kinase (PI3K) pathway 
in the regulation of dendritic cell (DC) functions. DCs are antigen-presenting cells 
that provide a link between innate and adaptive immunity and are required for 
initiation of specific T cell-driven immune responses. The present project 
concentrates on the possible regulation of DC functions by two PI3K-dependent 
kinases, Akt2/PKBβ and serum- and glucocorticoid-inducible kinase-1 (SGK1), 
which share 55% identity in their kinase domain regions. 
Akt2/PKBβ is known to be required for macrophage and DC migration, though the 
involved mechanisms remained undefined. On the other hand, DC migration is 
governed by Ca
2+
 signaling. In the present study, we addressed the mechanisms of 
Akt2-dependent DC migration by studying the possible involvement of Akt2 in Ca
2+
 
signaling. DCs were derived from the bone marrow of Akt2-deficient mice (akt2
-/-
) 
and their wild type littermates (akt2
+/+
) and their maturation was induced by 
lipopolysaccharides (LPS, 1μg/ml). Chemokine CCL21 (25 ng/ml)-induced 
migration of mature akt2
-/- 
DCs was impaired compared to akt2
+/+ 
DCs. In Ca
2+
 
imaging experiments, CCL21 (75 ng/ml)-triggered increase in cytosolic Ca
2+
 
concentrations ([Ca
2+
]i) was also significantly diminished in mature akt2
-/-
DCs. 
Moreover, release of Ca
2+
 from intracellular stores induced by thapsigargin (1 µM) 
and the following store-operated Ca
2+
 entry (SOCE) were reduced in mature akt2
-/-
DCs. Stimulation of P2Y receptors with ATP (100 µM) resulted in IP3-dependent 
Ca
2+
 release, which was also significantly decreased in mature akt2
-/- 
DCs. IP3-
induced activation of Ca
2+
 release-activated Ca
2+
 (CRAC) channels measured in 
whole cell patch-clamp experiments was significantly lower in mature akt2
-/- 
DCs. 
Analysis of the expression of IP3 receptor isoforms in akt2
+/+ 
DCs and akt2
-/- 
DCs by 
RT-PCR revealed a significantly impaired transcript of IP3R2 in akt2
−/−
DCs. Upon 
1h of LPS stimulation mRNA abundance of IP3R2 was increased in akt2
+/+
 but not in 
akt2
−/− 
DCs. Accordingly, protein abundance of IP3R2, analyzed by western blot, was 
reduced in mature akt2
−/−
DCs. mRNA abundance of transcription factor Ets1, which 
is known to upregulate the IP3R2 transcription, was significantly lower in immature 
akt2
-/- 
DCs than in akt2
+/+ 
DCs. Similarly to IP3R2, mRNA level of Ets1 was 
upregulated by LPS (1h) in akt2
+/+ 
but not in akt2
-/- 
DCs. ETS1 protein had lower 
expression in mature akt2
-/- 
DCs compared to akt2
+/+
 DCs. DC migration was 
sensitive to the IP3R inhibitor Xestospongin C (5 µM), which significantly decreased 
CCL21-induced migration of akt2
+/+
DCs and abrogated the differences between 
genotypes. Finally, knock-down of ETS1 with siRNA led to impaired RNA 
abundance of IP3R2, thapsigargin- and ATP-induced Ca
2+
 release from the stores, 
SOCE and CRAC channel activation, as well as DC migration. In conclusion, Akt2 
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upregulates IP3R2 transcription in DCs, presumably by enhancing the expression of 
ETS1 and this effect may underlie the stimulating effect of Akt2 on DC migration. 
On the other hand, PI3K activation suppresses proinflammatory cytokine production 
in DCs, which limits excessive T helper (Th1) polarization. Little is known about the 
mechanisms of PI3K-mediated suppression in DCs. The present study explored 
whether SGK1 can act as a negative regulator of DC functions downstream from 
PI3K. To this end, DCs were isolated from the bone marrow or from the spleen of 
gene targeted mice lacking functional SGK1 (sgk1
-/-
) and their wild type littermates 
(sgk1
+/+
). Expression of maturation markers, MHC II, CD86 and CD54, analyzed by 
flow cytometry, and secretion of interleukin IL-12 upon LPS (100 ng/ml) stimulation, 
determined by ELISA, were significantly higher and phagocytic capacity, assessed as 
FITC-dextran uptake, was significantly lower in sgk1
-/-
 than in sgk1
+/+
 DCs. 
Moreover, expression of CD86, MHCII and CD54 was also significantly higher in 
DCs isolated from the spleen of sgk1
-/-
 mice than those from sgk1
+/+
 mice. Moreover, 
the nuclear localization of the p65 subunit of the transcription factor NF-κB was 
significantly enhanced in sgk1
-/- 
DCs. N-myc downstream regulated gene 1 (NDRG-
1), the physiological substrate of SGK1, which is known to attenuate NF-κB 
signalling, was similarly expressed in sgk1
+/+
 and sgk1
-/-
 DCs, however SGK1-
dependent phosphorylation of NDRG-1 was decreased in sgk1
-/-
 DCs. Silencing of 
NDRG1 by siRNA in sgk1
+/+
 DCs led to an enhanced nuclear abundance of p65 
compared to the control empty vector-treated DCs. These observations point to an 
important role of SGK1 in the regulation of DC functions and thus disclose a novel 
element in the cross-talk between innate and adaptive immunity. Impaired 
phosphorylation of NDRG-1 in SGK1-deficient DCs may underlie enhanced nuclear 
localization of NF-κB and, accordingly, increased maturation and IL-12 production. 
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Abstrakt 
In der vorliegenden Studie wurde die Rolle des Phosphoinositol 3 Kinase (PI3K) 
Signalweges in der Regulation der Funktion Dendritischer Zellen untersucht. 
Dendritische Zellen sind Antigen-präsentierende Zellen, welche einen Link zwischen 
angeborener und adaptiver Immunität herstellen und für die Aktivierung von 
spezifischen T-Zellen erforderlich sind. Das gegenwärtige Projekt konzentriert sich 
auf die mögliche Regulation der Dendritischen Zellfunktion durch zwei PI3K-
abhängige Kinasen, Akt2/PKBβ und die Serum- und Glukokortikoid-induzierbare 
Kinase-1 (SGK1), welche 55% identische Kinasedomänenregion besitzen. 
Einerseits ist es bekannt, dass Akt2/PKBβ für Makrophagen und für die Migration 
Dendritischer Zellen erforderlich ist. Jedoch ist der involvierte Mechanismus noch 
weitgehend unerforscht. Andererseits wird die Migration Dendritischer Zellen vom 
Ca
2+
 Signalweg: reguliert. In der vorliegenden Studie wurde der Mechanismus der 
Akt2-abhängigen Migration in Dendritischen Zellen durch eine mögliche Beteiligung 
von Akt2 im Ca
2+
 Signalweg untersucht. Dendritische Zellen wurden aus dem 
Knochenmark von Akt2-defizienten Mäusen (akt2
-/-
) und ihren Wildtyp 
Wurfgeschwistern (akt2
+/+
) isoliert und anschließend die Reifung durch das 
Lipopolysaccharid (LPS, 1μg/ml) induziert. Das Chemokin CCL21 (25ng/ml) 
induziert die Migration von reifen akt2
+/+ 
und akt2
-/-
 Dendritischen Zellen. Jedoch 
war die Migration in akt2
-/-
 Dendritischen Zellen gegenüber akt2
+/+ 
Dendritischen 
Zellen signifikant reduziert. In Ca
2+ 
darstellenden Experimenten war die Gabe von 
CCL21(75 ng/ml) ein Auslöser für den Anstieg der zytosolischen Ca
2+
 Konzentration 
([Ca
2+
]i) in akt2
+/+
 Dendritischen Zellen, jedoch auch hier war die ([Ca
2+
]i) in reifen 
akt2
-/-
 Dendritischen Zellen signifikant vermindert.  
Darüber hinaus ist die Freisetzung von Ca
2+
 aus den intrazellulären Speichern durch 
Thapsigargin (1 µM) induziert. Auf dies folgt ein Speicher-abhängiger Ca
2+
 Einstrom 
(SOCE), welcher in reifen akt2
-/-
 Dendritischen Zellen signifikant reduziert war. Eine 
Stimulation des P2Y Rezeptors mit ATP (100µM) führte zu einem IP3-abhängigen 
Ca
2+
 Ausstrom, welcher in reifen akt2
-/-
 Dendritischen Zellen auch signifikant 
reduziert war. 
Eine IP3-induzierte Aktivierung des CRAC Kanals, gemessen in Ganzzell Patch-
Clamp Experimenten, war in reifen  akt2
-/- 
Dendritischen Zellen signifikant gemindert. 
Es wurden RT-PCR Analysen durchgeführt, bei diesen die Expression von IP3 
Rezeptor Isoformen in akt2
+/+
 und akt2
-/- 
Dendritischen Zellen ermittelt werden sollte. 
Dabei konnte festgestellt werden, dass eine geminderte Transkription von IP3R2 in 
akt2
−/− 
Dendritischen Zellen vorlag. Eine Inkubation mit LPS von einer Stunde, 
führte zu einer Stimulation der IP3R2 mRNA Konzentration in akt2
+/+ 
Dendritischen 
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Zellen, jedoch nicht in akt2
−/− 
Dendritischen Zellen. Demzufolge war auch die 
Proteinkonzentration von IP3R2, analysiert mit Hilfe eines Western Blots, in reifen 
akt2
−/− 
Dendritischen Zellen reduziert. 
Die mRNA Konzentration des Transkriptionsfaktors Ets1, welcher bekannt ist, dass 
er die Transkription von IP3R2 hochreguliert, war in unreifen akt2
−/− 
Dendritischen 
Zellen gegenüber akt2
+/+
 Dendritischen Zellen signifikant erniedrigt. Ähnlich zu 
IP3R2, war die mRNA Konzentration von Ets1 durch die Inkubation mit LPS (1 
Stunde) in akt2
+/+
 Dendritischen Zellen gegenüber akt2
−/− 
Dendritischen Zellen 
signifikant erhöht. Des Weiteren war die Expression des ETS1 Proteins in reifen 
akt2
−/− 
Dendritischen Zellen gegenüber akt2
+/+
 Dendritischen Zellen verringert.  
Die CCL21-induzierte Migration von akt2
+/+
 Dendritischen Zellen wurde durch die 
Hemmung von IP3R mit dem Inhibitor Xestospongin C (5µM) signifikant reduziert. 
Dadurch wurde der Unterschied in der CCL21-induzierten Migration zwischen den 
beiden Genotypen aufgehoben. 
Schlussendlich führt eine Inhibierung von ETS1 mit Hilfe einer siRNA zu einer 
reduzierten RNA Konzentration von IP3R2, einer Thapsigargin- und ATP-
induzierten Ca
2+
 Freisetzung aus den Speichern, SOCE und CRAC Kanal 
Aktivierung, sowie zu einer Migration Dendritischer Zellen. Zusammenfassend kann 
man sagen, dass Akt2 die IP3R2 Transkription in Dendritischen Zellen hochreguliert. 
Dies geschieht wahrscheinlich über eine Erhöhung der ETS1 Expression, wobei es 
wahrscheinlich zu einem stimulierenden Effekt von Akt2 auf die Migration 
Dendritischer Zellen führt.  
Die Aktivität von PI3K hemmt die Produktion von proinflammatorischen Zytokinen 
in Dendritischen Zellen. Diese Hemmung wirkt limitierend auf die übermäßige T-
Helfer (Th1) Polarisation. Wenig ist über den Mechanismus der PI3K-vermittelten 
Unterdrückung in Dendritischen Zellen bekannt. In der vorliegenden Studie soll 
untersucht werden, ob SGK1 als ein negativer Regulator in der Funktion 
Dendritischer Zellen, der PI3K nachgeschaltet, fungiert. Zu diesem Zweck wurden 
Dendritische Zellen aus dem Knochenmark oder der Milz aus SGK1 defizienten 
Mäusen (sgk1
-/-
) und ihren Wildtyp Wurfgeschwistern (sgk1
+/+
) isoliert. Die 
Expression der Reifungsmarker MHCII, CD86 und CD54, welche mit Hilfe der 
Durchflusszytometrie analysiert wurden, und die Sekretion von Interleukin-12 (IL-12) 
nach Stimulation mit LPS (100 ng/ml), gemessen mit Hilfe eines ELISA‘s, war in 
sgk1
-/-
 gegenüber sgk1
+/+
 Dendritischen Zellen signifikant erhöht. Im Gegensatz dazu 
war die Phagozytose, gemessen mit Hilfe der FITC-Dextran Aufnahme, in sgk1
-/-
 
gegenüber sgk1
+/+
 Dendritischen Zellen signifikant reduziert. Darüber hinaus war die 
Expression von CD86, MHCII und CD54 in den Dendritischen Zellen signifikant 
höher, welche aus der Milz von sgk1
-/-
 als diejenigen aus sgk1
+/+
 Mäusen isoliert 
wurden. 
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Des Weiteren war die nukleäre Lokalisation der Untereinheit p65, des 
Transkriptionsfaktors NF-κB, in sgk1-/- Dendritischen Zellen signifikant erhöht. N-
myc downstream regulated gene 1 (NDRG-1), das physiologische Substrat von 
SGK1, welches bekannt ist, dass es den NF-κB Signalweg abmindert, war 
gleichermaßen in sgk1
+/+
 und sgk1
-/-
 Dendritischen Zellen exprimiert. Jedoch war die 
SGK1-abhängige Phosphorylierung von NDRG-1 in sgk1
-/-
 Dendritischen Zellen 
vermindert. 
Eine Herunterregulation von NDRG1 durch eine siRNA in sgk1
+/+ 
Dendritischen 
Zellen führte gegenüber der Kontroll-siRNA zu einer erhöhten Konzentration an p65 
im Kern. Diese Untersuchungen weisen auf eine wichtige Rolle von SGK1 in der 
Regulation der Funktion  Dendritischer Zellen hin. Dies zeigt auf, dass SGK1 ein 
wichtiges Element in der Vernetzung zwischen angeborener und adaptiver Immunität 
ist. Eine erhöhte Phosphorylierung von NDRG-1 in SGK1 defizienten Dendritischen 
Zellen führt wahrscheinlich zu einer nukleären Lokalisation von NF-κB und im 
Anschluss zu einer erhöhten Reifung und IL-12 Produktion Dendritischer Zellen. 
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1. Introduction 
1.1 Role of Dendritic Cells 
The immune system is composed of two major subdivisions, i.e., the antigen (Ag)-
nonspecific innate immunity, which was discovered by Elie Metchnikoff in 1891, 
and the Ag-specific adaptive immunity, discovered by Paul Ehrlich in 1900 
(Kaufmann 2008; Paul 2011).  
When the pathogen breaks through the physiological barrier in our body, it will 
encounter the innate immune system, the first line of defense. The innate immune 
system has two crucial abilities(Janeway and Medzhitov 2002), i.e., to rapidly 
recognize pathogens and/or tissue injury and to signal the presence of danger to cells 
of the adaptive immune system, the second line of defense. Phagocytic cells, nature 
killer (NK) cells, complement, and interferons (IFNs) are the main players in the 
innate immune system. These players express a variety of pattern recognition 
receptors to identify molecular patterns that are associated with microbial pathogens 
such as bacterial lipopolysaccharide (LPS), carbohydrates, and double-stranded viral 
RNA. 
The adaptive immune system, besides being the second line of defense, also affords 
protection against re-exposure to the same pathogen(Sun, Beilke et al. 2009). The 
key features of the adaptive immune system are the abilities to rearrange genes of the 
immunoglobulin family, permitting the creation of a large diversity of Ag-specific 
clones and immunological memory.  
Each of the major subdivisions of the immune system has both cellular and humoral 
components to carry out its protective function. Although these two subdivisions 
have distinct functions, there is interplay between them. Dendritic cells (DCs) act as 
antigen presenting cells (APCs) and become the link between these two parts (Fig. 1) 
(Banchereau, Briere et al. 2000; Lipscomb and Masten 2002). 
DCs are the most efficient APCs owing to their unique ability of inducing primary 
immune responses, therefore permitting the establishment of immunological memory. 
Besides inducing adaptive immune responses to foreign antigens (Ags), DCs are also 
crucial for maintaing immune tolerance(Lewis and Reizis 2012). DCs were named 
for their probing, tree-like shapes (from the Greek ‗dendron‘, meaning tree), which 
were first described by R.Steinman and Z.Cohn in 1973(Steinman and Cohn 1973).  
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All DCs are ultimately derived from hematopoietic stem and progenitor cells in the 
bone marrow (Merad and Manz 2009). Hematopoietic stem and progenitor cells give 
rise to several distinct progenitors that can be differentiated into one or more DC 
subsets. DCs can be divided into two major populations: the type I interferon-
producing plasmacytoid DCs (pDCs) and conventional DCs (cDCs) expressing the 
surface marker CD11c. Both populations express class II major histocompatibility 
complex (MHC-II) (LeibundGut-Landmann, Waldburger et al. 2004; Naik, Sathe et 
al. 2007; Alvarez, Vollmann et al. 2008). The human pDCs express the surface 
marker CD123, two additional markers, BDCA-2(CD303) and BDCA-4(CD304), 
and they are restricted to peripheral blood and bone marrow (Barchet, Blasius et al. 
2005; McKenna, Beignon et al. 2005). Unlike human pDCs, mouse pDCs express the 
cell surface antigens B220 and Ly6C. Moreover, mouse pDCs express CD11c, 
although in low amounts compared with cDCs, and, except in mice treated with the 
cytokine Flt3 ligand, they do not express CD123 (IL-3α). Mouse pDC express BST-2 
(mPDCA) and Siglec-H and are negative for CD11b. cDCs subset is the predominant 
DC population in the steady state (Colonna, Trinchieri et al. 2004; de Heer, Hammad 
et al. 2005). Moreover, upon activation, respiratory cDCs produce a range of 
inflammatory mediators (de Heer, Hammad et al. 2005; Beaty, Rose Jr et al. 2007). 
Nonlymphoid tissue cDCs emigrate continuously via lymphatics into draining lymph 
nodes; similar to the resident populations of lymphoid tissue DCs, most migrant 
cDCs die in lymphoid tissue and do not reenter the blood circulation. Strong 
inflammatory stimuli can cause an abrupt decrease in the number of lymphoid cDCs, 
a consequence of maturation-induced apoptosis and migration(Naik, Sathe et al. 
2007).  
Figure 1.  The life cycle of dendritic cells, obtained from J Banchereau Et Al. 
Annual Review of Immunology, 2000 
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1.2 Maturation of Dendritic Cells 
DC progenitors are not restricted to bone marrow and can be found in multiple 
locations. These progenitors can differentiate into immature DCs in peripheral tissues 
(Ocular Periphery and Disorders, Darlene A. Dartt). Immature DCs express only a 
small amount of MHC II and no co-stimulatory molecules. A major functional 
characteristic of immature DCs is the capacity for continuous endocytosis in the 
steady state (Lutz and Schuler 2002; Wilson, El-Sukkari et al. 2004). Thus, immature 
DCs are able to capture Ags but are still not able to determine T-cell fate and prime 
immune responses. Once peripheral tissues are inflamed or infiltrated by microbes, 
immature DCs become activated (Banchereau, Briere et al. 2000; Lutz and Schuler 
2002). After capturing and processing Ags, they migrate to second lymph organs, 
and give rise to mature DCs that downregulate antigen-sampling functions but 
become exceedingly powerful at priming T cells (Alvarez, Vollmann et al. 2008).  
Mature DCs express high cell-surface levels of antigen-presenting MHC molecules 
and costimulatory molecules CD40, CD80, CD83, and CD86 (Banchereau, Briere et 
al. 2000). They produce large amounts of proinflammatory cytokines, such as IL-12, 
IL-18, and TNFα (Lin, Jacek et al. 2006; Schmidt, Nino-Castro et al. 2012). Thus, 
DCs are capable of inducing TH1- and TH2-cell differentiation, and cytotoxic T 
lymphocyte response. 
Besides the functional changes, as acquisition of high cellular motility, the 
morphological changes also accompany DC maturation. This includes a loss of 
adhesive structures, and cytoskeleton reorganization (Banchereau, Briere et al. 2000; 
Alvarez, Vollmann et al. 2008; Randolph, Ochando et al. 2008). 
1.3 Migration of Dendritic Cells 
Due to the complex life cycle, the ability of DCs and their progenitors to migrate is a 
central feature of DCs and indispensable for their functions within the immune 
system (Alvarez, Vollmann et al. 2008). 
The migration of DCs entails 1) the ability of newly formed DCs or their progenitors 
to exit their place of birth and enter the blood, 2) the recruitment of the circulating 
cells into target tissues, 3) the extravascular lodging and interstitial motility needed 
to sample Ags, 4) the capacity to access lymph vessels to travel either to lymph 
nodes  or back to the blood, and 5) the ability to interact with migrating lymphocytes 
and other immune cells in a manner that allows the exchange of critical information 
regarding the nature and context of presented Ags (Alvarez, Vollmann et al. 2008).  
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As mentioned above, many DCs begin their journey with their release from the bone 
marrow into the blood and subsequent traffic into peripheral lymphoid and 
nonlymphoid tissues. In nonlymphoid tissues, DCs eventually proceed into lymph 
nodes  through afferent lymphatics and, in some instances, return back to the blood 
via the thoracic duct (von Andrian and Mempel 2003; Steinman and Hemmi 2006; 
Alvarez, Vollmann et al. 2008). Compartmental segregation of lymphoid tissues, 
which facilitates efficient surveillance and targeted cellular response, relies on the 
precise trafficking of immune cells between the circulation, tissues, and second 
lymph organs (von Andrian and Mempel 2003; Ricart, John et al. 2010). However, 
specific responses require directed cell migration that DCs accomplish through 
selective expression of chemokine receptors, coupled with generation of specific 
chemokine in immune organs. Specifically, immature DCs utilize specific chemokine 
receptor-ligand pathways, such as CCR2-CCL2 and, CCR5-CCL5, and CCR6-
CCL20, as well as CXCR3-CXCL10 and CXCR4- CXCL12 (SDF1-α) . However, 
after Ag capture when DCs become mature, they downregulate most of the above 
mentioned chemokine receptors, with the exception of CXCR4, while upregulating 
the crucial receptor CCR7. CCR7 has two cognate ligands, CCL19 (ELC, MIP-3 β) 
and CCL21 (SLC, 6Ckine, Exodus-2), which are highly expressed by peripheral 
lymphatic endothelial cells as well as LN stroma cells and guide DCs to second 
lymph organs (Banchereau, Briere et al. 2000; Le, Zhou et al. 2004; Rot and von 
Andrian 2004). To date 18 human chemokine receptors have been identified, among 
them four receptors are found on DCs (Table 1). Throughout its migration, DCs also 
require some other assistance to reach their targeted destination, such as highly 
regulated coordination of protrusion, retraction, adhesion, detachment, and major 
dynamic rearrangements of the actin cytoskeleton (Saarikangas, Zhao et al. 2009). 
Therefore DCs express E-cadherin and elastase and release type IV collagenase that 
may contribute to their migration (de Noronha, Hardy et al. 2005; Alvarez, Vollmann 
et al. 2008).  
Table 1. Details of human chemokine receptors, obtained from C Murdoch, A Finn. 
Blood, 2000 
Receptor Amino 
acids 
Base 
pairs 
Ligand (high affinity) Cellular 
distribution 
CXCR1(GPR5) 333 999 Lymphotactin T, B, NK 
CXCR1 (IL BRA) 350 1050 IL8, GCP2 N, M, T, NK, 
Bs, Ms, En 
CXCR2 (IL BRB) 355 1065 IL8, GRO-α, GRO-β, 
GRO-γ, NAP-2, ENA-
N, M, T, NK, 
As, Nn, Ms, 
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78, GCP-2, En,  
CXCR3 368 1104 IP-10, Mig, I-TAC Activated T, 
CXCR4* (LESTR, 
FUSIN) 
352 1056 SDF-1α, SDF-1β Myeloid, T, B, 
Ep, En, DC  
CXCR5 (BLR1) 372 1116 BCA-1 B  
CX3CR1 (V28) 355 1065 Fractalkline NK, M, T  
CCR1 355 1065 RANTES, MIP-1α, 
HCC-1, MCP-2, 
MCP-3, MIP-5, Ckβ8 
N, M, T, NK, 
B, Ms, As, Nn  
CCR2A 374 1122 MCP-1, MCP3, 
MCP4 
M  
CCR2B↑ 360 1080 MCP-1, MCP2, 
MCP3, MCP4 
M, T, B, Bs  
CCR3↑ 355 1065 Eotaxin, Eotaxin-2, 
Eotaxin-3, RANTES, 
MCP2,3,4, MIP-5 
Eo, Bs, T  
CCR4 360 1080 TARC, MDC T, P  
CCR5↑ (ChemR13) 352 1056 RANTES, MIP-1β, 
MIP-1α, MCP-2 
T, M, MØ, DC  
CCR5 (STRL22, 
DRY-6, GPR-CY4, 
CKR-L3) 
374 1122 MIP-3α T, B, DC  
CCR7 (BRL2, EBI1) 
CCR8*↑ (TER1, 
CKR-L1, ChemR1) 
CCR9 (GPR-9-6) 
378 
355 
 
1134 
1065 
 
MIP-3β, 6-C-kine 
I-309 
 
T, B, DC  
M, Thymus 
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In general, migration of any cell involves three components: the formation and 
maintenance of cell polarity, activation of motility machinery for linear locomotion, 
and turning or changing direction of movement in response to gradients of 
environmental cues (Pollard and Borisy 2003; Philipsborn and Bastmeyer 2007; 
Petrie, Doyle et al. 2009). Besides sensing of signal gradients, chemotaxis of 
eukaryotes requires the polar differentiation of the cells. A leading edge called the 
lamellopodia and a trailing edge called the uropod (or rear end) characterize the 
polarized migrating cells [general about migration, section 1.3] (Small, Stradal et al. 
2002; Philipsborn and Bastmeyer 2007; Alvarez, Vollmann et al. 2008; Saarikangas, 
Zhao et al. 2010).  
Calcium release by the PLC-IP3-IP3R pathway at the rear was thought to be the 
major source to counteract the biophysics of calcium diffusion and maintain the 
calcium gradient which is important for maintaining cell polarity [complicated 
sentence and you call this part Ca
2+
 signaling in DC migration, so now you should 
really write about DCs] (Clapham 2007; Bononi, Agnoletto et al. 2011).  It has been 
demonstrated that an extracellular Ca
2+
 influx is required for positive feedback at the 
leading edge of spontaneously polarized macrophages [you may use it for Discussion 
but not here] (Evans and Falke 2007). Inhibition of extracellular Ca
2+
 influx leads to 
loss of leading-edge PI3K activity, disassembly of F-actin, cessation of ruffling, and 
decay of chemoattractant signals (Evans and Falke 2007). Conversely, increasing 
cytosolic Ca
2+
 enhances membrane ruffling, PI3K activity, and F-actin accumulation.  
In DCs, chemotactic chemokines, such as CXCL12 and CCL21, rapidly increase 
intracellular free Ca
2+
 concentration ([Ca
2+
]i) by triggering Ca
2+
 release from 
intracellular stores followed by the store-operated Ca
2+
 (SOC) entry (Barbet, Demion 
et al. 2008; Nurbaeva, Schmid et al. 2012). Inhibition of SOC channels leads to 
profound changes in DC migration. Blocking of SOC channels impairs CCL21-
dependent migration (Matzner, Zemtsova et al. 2008; Xuan, Shumilina et al. 2009). 
On the other hand, ion channels that control Ca
2+
 flux by setting the membrane 
potential are also important regulators of DC migration. Ca
2+
 influx brings about a 
strong local depolarization of the cell membrane, and consequently to sustain Ca
2+
 
entry, activity of other channels, which can prevent depolarization, is required. In 
D6 (CCR107) 
DARC (Duffy 
antigen) 
369 
384 
338 
1107 
1152 
1014 
TECK 
MCP-1, MCP-3 
IL8, GRO-α, 
RANTES, MCP-1, 
MCP-3, MCP-4, 
Eoxtaxin 
T, Thymus 
Placenta, liver 
En, RBC, T 
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mouse DCs ion channels that support Ca
2+
 influx by hyperpolarizing the membrane 
and thereby providing electrical driving force for Ca
2+
 entry are voltage-gated K+ Kv 
channels (Matzner, 2008) and Ca
2+
-activated Cl
-
 channel ANO6 (Kalina‘s paper). 
Accordingly pharmacological or genetical inhibition of Kv or ANO6 channels results 
in a strong impairment of DC migration (Nici‘s paper, Kala‘s paper). On the other 
hand, transient receptor potential cation channel of melastatin family TRPM4, which 
functions as a Ca
2+
-activated non-selective cation channel providing under 
physiological conditions influx of Na
+
 and therefore membrane depolarization, 
breaks the Ca
2+
 influx and prevents Ca
2+
 overload (Barbet, Demion et al. 2008). 
Interestingly, migration of TRPM4-deficient mouse DCs is also impaired, suggesting 
that [Ca
2+
]i should be perfectly balanced to enable DC migration.  
It has been demonstrated for various cell types that the polar differentiation of 
migrating cells is established and maintained by generating gradients of Ca
2+
 
concentrations through the concerted action of different Ca
2+
 channels and 
transporters.  
1.4 Mechanism of Ca
2+
 Release and Ca
2+
 Entry in 
Dendritic Cells  
Ca
2+
 can enter the cytoplasm from one of the two general sources: it can be released 
from intracellular stores, or extracellular Ca
2+
 can enter the cell across the plasma 
membrane (Bootman, Collins et al. 2001; Parekh and Putney 2005; Bootman 2006; 
Putney 2010). These two processes often occur either simultaneously or sequentially. 
Figure 2. Maintaining and using Ca2+ gradients for signaling, obtained from DE 
Clapham, Cell, 2007 
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The internal stores are held within the membrane systems of the endoplasmic 
reticulum (ER) or the equivalent organelle, the sarcoplasmic reticulum of muscle 
cells (Mazzarello, Calligaro et al. 2003; Rizzuto and Pozzan 2006). Ca
2+
 release from 
these internal stores is mediated by various channels, of which the inositol-1,4,5-
trisphosphate receptor (IP3R) and ryanodine receptor (RyR) families have been 
studied extensively (Mikoshiba 2007; Vanderheyden, Devogelaere et al. 2009; Rossi, 
Tovey et al. 2011). These two channel classes are regulated by several factors, 
among which the most important activator is Ca
2+
 itself.  
Calcium entry secondary to calcium release via IP3R activation is essential for 
modulating calcium-dependent processes, particularly in immunity. IP3 is a second 
messenger produced through phosphoinositide turnover in response to many 
extracellular stimuli. The IP3R is an IP3-gated Ca
2+
 release channel located on ER. If 
IP3 and Ca
2+
 are bound to an IP3R, it can open and Ca
2+
 will diffuse into the cytosol 
(Krebs and Michalak 2007; Mikoshiba 2007). IP3Rs have three isoforms, IP3R1, 2 
and 3. Most work has been performed on the ubiquitously expressed IP3R1, but it is 
however clear that various IP3R isoforms can subtly differ in their properties (Nadif 
Kasri, Bultynck et al. 2002; Vermassen, Parys et al. 2004). Their affinity for IP3 
displays a rank-order IP3R2>IP3R1>IP3R3. The open probability of IP3Rs depends 
on the IP3 concentration and the Ca
2+
 concentration in the cytosol (Rahman 2012). It 
increases with increasing IP3 concentration. It is low for low Ca
2+
 concentration, 
increases with increasing Ca
2+
 (100-300nM) and finally decreases again for even 
higher Ca
2+
 concentrations (above 300nM) (Bootman, Collins et al. 2001; Foskett, 
White et al. 2007; Vanderheyden, Devogelaere et al. 2009).  
RyRs also contain three different isoforms, RyR1, 2 and 3. RyRs are similar to the 
IP3R, and when stimulated transport Ca
2+
 into the cytosol (Blaustein, Greger et al. 
2001; Wehrens and Marks 2004). It is first demonstrated by O‘Connell and his 
colleagues that immature mouse DCs express functional RyR1 channels, but little or 
no RyR2 or RyR3, but the expression of RyR1 RNA is reduced dramatically upon 
maturation (O'Connell, Klyachko et al. 2002). Later, O‘Connell has used RyR1 KO 
mice as a model; their study shows that RyR1 alone is not essential for BMDC 
functions. Signaling via IP3Rs appears to be sufficient to mediate Ca
2+
 signaling in 
mouse DCs (Stolk, Leon-Ponte et al. 2006). In contrast, in human DCs, RyR1 is 
important for the maturation and activation (Bracci, Vukcevic et al. 2007). 
Recognizing Ca
2+
 on its cytosolic side establishes a positive feedback mechanism, 
because a small amount of Ca
2+
 in the cytosol near the receptor will cause it to 
release even more Ca
2+
 (Fill and Copello 2002). The autocatalytic process of Ca
2+
-
induced Ca
2+
 release (CICR) enables the IP3Rs and RyRs to communicate with each 
other to establish coordinated Ca
2+
 signals (Ashby, Craske et al. 2002; Smith and 
Parker 2009; Taylor and Tovey 2010). The released Ca
2+
 is pumped back either into 
the ER by Sacro-Endoplasmic Reticulum Calcium ATPases (SERCA pumps) or out 
of the cell via plasma membrane Ca
2+
 ATPase (PMCA pumps). To maintain low 
cytoplasmic [Ca
2+
]i, ATPase exchange protons for two (SERCA) or one (PMCA) 
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Ca
2+
 per hydrolyzed ATP (Bootman, Collins et al. 2001; Feske 2007; Scharenberg, 
Humphries et al. 2007). Another extrusion mechanism is the exit of Ca
2+
 out from 
the cell via the K
+
-independent Na
+
/Ca
2+
 exchangers (NCX, or SLC8A1-3), and K
+
-
dependent Na
+
/Ca
2+
- exchangers (NCKX; SLC24A1-5). These transporters exchange 
one Ca
2+
 ion for three Na
+
 ions (NCX) or cotransport one K
+
 ion with one Ca
2+
 ion in 
exchange for four Na
+
 ions (NCKX). PMCAs and NC(K)X complement each other: 
PMCAs are effective at maintaining low internal [Ca
2+
]i over long durations, whereas 
NCX and NCKX can make the rapid adjustments (Parekh and Putney 2005; Feske 
2007). 
In spite of its importance, the Ca
2+
 release phase is transient, sometimes fully 
deactivating within a few tens of seconds, as the ER Ca
2+
 stores are necessarily 
limited. Decreased Ca
2+
 within the ER triggers a process known as store operated 
calcium (SOC) entry, in which Ca
2+
 channels in the plasma membrane are activated 
to allow Ca
2+
 to enter from the essentially unlimited extracellular Ca
2+
 pool to the 
cytosol (Feske 2007; Scharenberg, Humphries et al. 2007). SOC entry does more 
than simply providing Ca
2+
 for refilling the stores, it itself generates sustained Ca
2+
 
signals that control such essential functions as gene expression, cell metabolism and 
exocytosis. The best characterized SOC channels in DCs are known as ‗calcium 
release-activated calcium‘ (CRAC) channels. DCs have been shown to possess 
CRAC channels as a main Ca
2+
 entry pathway (Hsu, O' Connell et al. 2001). 
Accordingly, Ca
2+
 influx is enhanced by membrane hyperpolarization. CRAC 
channels are highly Ca
2+
-selective channels of a low conductance with a 
characteristic inwardly rectifying current-voltage relationship. The stromal 
interaction molecule 1 (STIM1) has been identified as the ER-resident Ca
2+
 sensor 
and calcium release-activated calcium modulator 1 (CRACM 1); also called Orai1, 
functions as the pore-forming subunit of CRAC channels (Vig, Peinelt et al. 2006). 
In mammals, several homologs of these proteins exist: STIM1 and STIM2 in the ER 
and Orai1, Orai2, and Orai3 in the plasma membrane (Parvez, Beck et al. 2008; Vig 
and Kinet 2009). A strong functional interaction between STIM1 and Orai1 has been 
demonstrated by many laboratories. STIM1 and Orai1 are necessary and sufficient to 
generate CRAC-like currents in vitro (Smyth, Hwang et al.; Park, Hoover et al. 2009; 
Hogan, Lewis et al. 2010; Srikanth and Gwack 2012). After store depeletion, in 
response to decreased ER Ca
2+
 concentrations, STIM1 aggregates and translocates to 
form oligomers, moves to the ER-PM junctions, and close to the regions of Ca
2+
 
influx from the plasma membrane (Hewavitharana, Deng et al. 2007; Carrasco and 
Meyer 2011; Cheng, Liu et al. 2011).  
Whereas much evidence has been accumulated that Ca
2+
 gradients are indispensable 
for DC migration, very little is known how ion channels and transporters generating 
or controlling Ca
2+
 signals are regulated in DCs. The present study concentrates on a 
signaling pathway that plays an important role in DC biology, which is the 
phosphatidylinositol-3-kinase (PI3K) pathway.  
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1.5 PI3K-PDK1-Akt/SGK1 Pathway  
1.5.1  Role of PI3K in DCs  
Phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases essential for diverse 
physiological reactions. The lipid products produced by PI3Ks include PI(3)P, 
PI(3,4)P2 and PI (3,4,5)P3(Rameh and Cantley 1999; Koyasu 2003; Liu, Cheng et al. 
2009).  
The PI3K family can be divided into three classes—class I, II and III. Each type of 
PI3K contains a C2 domain and a catalytic domain connected by a helical domain 
(Walker, Perisic et al. 1999; Bader, Kang et al. 2005). We are interested in the class I 
PI3Ks, since it is the only class which has been show to activate protein kinase B 
(PKB; also called Akt) in DCs (Vanhaesebroeck and Alessi 2000; Okkenhaug and 
Vanhaesebroeck 2003).  
The class I PI3Ks is subdivided into class IA and the class IB subclasses based on the 
differences in their activation mechanisms. The class IA PI3Ks are heterodimeric 
enzymes having three types of the catalytic subunit: p110α, p110β and p110γ 
(Vanhaesebroeck and Waterfield 1999; Okkenhaug and Vanhaesebroeck 2003; 
Hirsch, Costa et al. 2007) and five regulatory subunits: p85α, p85β, p55α, p55β and 
p55γ. The class IA PI3Ks can be activated by tyrosine-kinase-associated receptors, 
including antigen, co-stimulatory and cytokine receptors (Koyasu 2003; Okkenhaug 
and Vanhaesebroeck 2003). For example, interleukin 2 (IL-2), IL-3, IL-6, 
granulocyte colony-stimulating factor and interferons (IFNs) activate class IA PI3Ks 
Figure 3. Structural characteristics of the PI3K family, obtained from 
S Koyasu, Nature Immunology, 2003 
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in many immune cells, including T cells and DCs (Koyasu 2003). The single class IB 
PI3k enzyme has only one catalytic subunit and one regulatory subunit: p110γ and 
p101, respectively. P110γ is expressed only in mammals, mainly in leukocytes. The 
class IB PI3K is activated by G-protein-coupled receptors (GPCRs), including the 
chemokine receptors (Beer-Hammer, Zebedin et al.; Fruman and Cantley 2002; 
Saudemont and Colucci 2009).  
The preferential substrate of the class I PI3Ks is PI(4,5)P2. The class I PI3Ks can 
phosphorylate PI(4,5)P2 to generate PI(3,4,5)P3 at the inner leaflet of the plasma 
membrane. PI(3,4,5)P3 acts as a binding site for pleckstrin-homology (PH) domains 
(Vanhaesebroeck and Alessi 2000; Tessier and Woodgett 2006). The subset of PH 
domains bind to PI (3, 4)P2 and PI(3,4,5)P3 with higher affinity than other PIs. 
Typically, following growth factor activation of PI3K, proteins with PH domains, 
such as PKB and phosphoinositide-dependent kinase 1 (PDK1), are translocated to 
the site where PI(3,4,5)P3 is generated at the plasma or endosomal membranes 
(Scheid, Parsons et al. 2005). There, they interact with other proteins or become 
activated by PI(3,4)P2 or PI(3,4,5)P3 binding. In fact PKB, which is recruited to the 
PM by binding PI(3,4)P2 or PI(3,4,5)P3, is considered to be a chief downstream 
target of PI3K (Vanhaesebroeck and Alessi 2000; Liao and Hung 2010; Yang, Wu et 
al. 2010). 
Many studies indicate that PI3Ks have pleiotropic roles in immune cell activation 
and function (Koyasu 2003; Okkenhaug and Vanhaesebroeck 2003; Koyasu 2004). 
In DCs, PI3K is considered to belong to the gate-keeping system, which controls the 
maturation and survival of DCs, and prevents excessive immune responses (Fukao, 
Tanabe et al. 2002; Fukao and Koyasu 2003; Shumilina, Zahir et al. 2007; Krawczyk, 
Holowka et al. 2010). PI3K is activated by LPS, peptidoglycan, CD40 ligand, RANK 
ligand, and CpG oligonucleotides, all of which induce production of 
proinflammatory cytokines, such as IL-12, and provide a negative feedback 
regulation of IL-12 production (Fukao, Tanabe et al. 2002; Fukao and Koyasu 2003). 
 
Figure 4. PI3K-PDK1 pathway, obtained from Yang KJ, J Biol Chem, 2008 
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1.5.2 PDK1 and PDK1 Functions in DCs 
One downstream target of PI3K is PDK1, which is a 63 kDa serine/threonine kinase 
belonging to the AGC superfamily of protein kinases. It phosphorylates a variety of 
other protein kinases within the AGC subfamily including PKC isoforms, p70 S6K, 
Rsk, serum and glucocorticoid-inducible kinases (SGKs) and PKB/Akt 
(Vanhaesebroeck and Alessi 2000; Woodgett 2005; Tessier and Woodgett 2006; 
Gurevich, Tesmer et al. 2011). In fact, PDK1 was first discovered by its capacity to 
phosphorylate PKBα/Akt1 at Thr 308 (Alessi, James et al. 1997; Bayascas, 
Wullschleger et al. 2008; Calleja, Laguerre et al. 2009).  
PDK1 has two domains: the N-terminal catalytic domain and the C-terminal PH 
domain (Mora, Komander et al. 2004; Yang, Shin et al. 2008). The catalytic domain 
has three ligand binding sites: the substrate binding site, the ATP binding site, and 
the docking site. The docking site is also known as PKC related kinase 2- interacting 
factor- pocket (PIF-pocket), it acts as the binding site for the hydrophobic motif of 
other AGC kinases (Mora, Komander et al. 2004; Woodgett 2005; Li, Yang et al. 
2010). PDK1 activates at least 23 AGC kinases by phosphorylating a specific Thr or 
Ser residue located within the T-loop of the kinase domain(Vanhaesebroeck and 
Alessi 2000; Mora, Komander et al. 2004; Komander, Kular et al. 2005). Of note, 
PDK1 has no hydrophobic motif. The catalytic activity of PDK1 is not acutely 
regulated, thus some targets are constitutively phosphorylated. The PH domain 
function is mainly to enable the interaction of PDK1 with PI(3,4)P2 and PI(3,4,5)P3 
(Vanhaesebroeck and Alessi 2000; Komander, Fairservice et al. 2004; Tessier and 
Woodgett 2006). PDK1 only encounters some of its kinase substrates, as Akt/PKB at 
the plasma membrane. However, PDK1 can also translocate to the nucleus in 
response to mitogens (Roelants, Torrance et al. 2004; Scheid, Parsons et al. 2005; 
Woodgett 2005).  
In the past few years, the crucial role of PDK1 in embryonal development as well as 
in normal functions of the liver and heart has been well studied using specific tissue 
deletion in mice (Lawlor, Mora et al. 2002; Mora, Lipina et al. 2005; Mora, 
Sakamoto et al. 2005; Zaru, Mollahan et al. 2008; Di, Feng et al. 2010). Several 
studies have addressed the role of PDK1 in T lymphocytes. PDK1 regulates T cell 
development and controls the production of IL-4 by Th2 cells (Hinton, Alessi et al. 
2004; Nirula, Ho et al. 2006). DCs derived from PDK1 deficient mice have several 
abnormal aspects in vitro, though a normal in vivo development. PDK1-
hypomorphic DCs have a reduced TLR-induced macropinocytosis as well as FcR-
mediated phagocytosis but enhanced antigen presentation, increased levels of 
costimulatory molecules and enhanced production of cytokines (IL-12 and IL-10) 
(Zaru, Mollahan et al. 2008). Thus, similar to PI3K, PDK1 has also a suppressive 
effect on DC maturation and cytokine production. 
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1.5.3 Akt and Akt Functions in DCs 
PKB/Akt has been identified as a protein kinase with extensive homology with 
protein kinases A and C, and was therefore termed PKB (Manning and Cantley 
2007). On the other hand, PKB/Akt is the cellular homologue of the viral 
oncoprotein v-Akt, and is therefore referred to Akt. The Akt family has three 
isoforms: Akt1, 2 and 3 (also known as PKB α, β and γ), which share a high degree 
of amino acid identity. 
Akt is a 57kDa Ser/Thr kinase with three functional domains: an N-terminal PH 
domain, a kinase domain and a C-terminal hydrophobic motif (Calleja, Laguerre et al. 
2009). PH domain preferentially binds PI(3,4,5)P3 and PI(3,4)P2 over other PIs 
(Huang and Sauer 2010; Dixon, Gray et al. 2011). The catalytic domain of Akt is 
structurally similar to other protein kinases of AGC family, including PKA and 
p70S6K, but is most similar to SGKs (Brunet, Park et al. 2001; Scheid and Woodgett 
2003; Woodgett 2005; Loffing, Flores et al. 2006). Akt is cytosolic in unstimulated 
cells, translocates to the plasma membrane upon activation of PI3K. As indicated 
earlier, PI3K stimulation leads to the production of PI(3,4,5)P3. PDK1 and Akt are 
recruited to the membrane via binding of their PH domains to PI(3,4,5)P3 (Koyasu 
2003; Okkenhaug and Vanhaesebroeck 2003; Mora, Komander et al. 2004; 
Yoshizaki, Mochizuki et al. 2007). Colocalization of PDK1 and Akt induces the 
phosphorylation of Ser 473 at the hydrophobic motif site of Akt, and in further 
causes the phosphorylation of Thr 308 at the T-loop site of Akt (Mora, Komander et 
al. 2004; Calleja, Laguerre et al. 2009; Li, Yang et al. 2010). Finally, dually 
phosphorylated Akt detaches from the plasma membrane and translocates through 
the cytosol to the nucleus (Manning and Cantley 2007). Activation of Akt and 
phosphorylation of both these residues are abolished if the cells are incubated with 
PI3K inhibitors prior to stimulation with agonist. Phosphorylation of both residues, 
Thr308 in the kinase domain and Ser473 in the C-terminal regulatory domain, is 
essential for maximal activation of Akt1 (Tessier and Woodgett 2006; Manning and 
Cantley 2007). The Akt2 and Akt3 isoforms are also activated in response to agonists 
which activate PI3K, by phosphorylation of the residues equivalent to Thr308and 
Figure 5. Classification and domain structure of AKT family members, obtained 
from S Song, L Salmena, PP Pandolfi, Nature Reviews Molecular Cell, 2012 
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Ser473 (Crellin, Garcia et al. 2007; Warfel, Niederst et al. 2011). Mutation of either 
residue of Akt1 to Ala does not prevent the other one from becoming phosphorylated 
in response to insulin, indicating that the phosphorylation of these residues can occur 
independently from each other (Vanhaesebroeck and Alessi 2000; Lawlor and Alessi 
2001; Richardson, Schalm et al. 2004).  
The Akt is a central node in cell signaling downstream of growth factors, cytokines, 
and other cellular stimuli (Manning and Cantley 2007). Akt plays a key role in 
multiple cellular processes such as cell survival, growth, proliferation, angiogenesis, 
metabolism, and migration (Song, Ouyang et al. 2005; Bononi, Agnoletto et al. 2011).  
Numerous substrates of Akt have been identified. Thus, Akt may influence plasma 
membrane and intracellular proteins involved in ionic intracellular homeostasis such 
as sarco(endo)plasmic reticulum Ca
2+
 ATPase (Rota, Boni et al. 2005) and ryanodine 
receptors (Barac, Zeevi-Levin et al. 2005). Akt-mediated transcriptional up-
regulation of NCX1 and NCX3 has been found in a study on PC12 cells (Formisano 
et al. 2008). A consensus sequence for Akt phosphorylation (RxRxxS/T) is present in 
all three types of IP3Rs that indicate the IP3R as a target of Akt (Khan, Wagner Ii et 
al. 2006; Pinton, Giorgi et al. 2008; Hwang, Duncan et al. 2009; Martin, Wang et al. 
2012). Akt phosphorylates type-I IP3R and therefore inhibits Ca
2+
 release from the 
ER and prevents Ca
2+
 induced apoptosis in non-cardiac cells (Khan et al.2006; Szado 
et al.2008). Several transcription factors are downstream targets of Akt. Among them 
are NF-κB, CREB, FoxO2 (Tessier and Woodgett 2006), ETS1 (Lavenburg, Ivey et 
al. 2003).  
DCs express Akt1 and Akt2, but not Akt3 (Li, Syrovets et al. 2009). Dongsu et al. 
has provided evidences that Akt1 regulates DC survival in innate (LPS-driven) and 
adaptive (CD40-driven) immune responses. In addition, Akt deficiency leads to 
defective DC activation and survival (Park, Lapteva et al. 2006). Although Akt1 is a 
predominant family member in bone marrow-derived DCs (BMDCs), Akt2 also 
plays an important role in the plasmin-triggered chemotactic response of monocyte-
derived DCs (Li, Syrovets et al. 2009). Moreover, in macrophages, it has been shown 
that Akt2 directly mediates the signal transduction pathway, which regulates actin 
polymerization and chemotaxis (Zhang, Ma et al. 2009). However, very little is 
known about the mechanisms of Akt2-dependent regulation of migration. In the 
present project, the role of Akt2 in DC migration and in other Ca
2+
-dependent 
functions was addressed. 
1.5.4 Ets-1 
One of the transcriptional factors regulated by Akt is ETS1 (Lavenburg, Ivey et al. 
2003). ETS proteins are a family of transcription factors that regulate the expression 
of a myriad of genes in a variety of tissues and cell types (Remy and Baltzinger 2000; 
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Verger and Duterque-Coquillaud 2002; Hollenhorst, McIntosh et al. 2011). The 
name ―Ets‖ stems from a sequence that was detected in an avian erythroblastosis 
virus, E26 carring the v-est oncogene (Sharrocks 2001; Pham, Lawson et al. 2007). 
The newly discovered sequence was called E26 transformation specific sequence or 
Ets (Blair and Athanasiou 2000; Dittmer 2003). This family was originally defined 
by the presence of a conserved DNA binding domain, the Ets domain (Span, 
Manders et al. 2002; Dwyer, Li et al. 2007). ETS proteins are composed of 85 amino 
acids, with 4 tryptophan repeats DNA-binding domain that recognizes DNA 
sequences containing a GGAA/T core motif (Sharrocks 2001; Dittmer 2003). In 
mouse, the ETS family consists of 28 members and it is known to control important 
biological processes, including cellular proliferation, differentiation, lymphocyte 
development and activation, apoptosis and migration in different cell types such as B 
cells, endothelial cells, fibroblasts and fibroblasts (Koskela and Lassila 2003; Wang, 
John et al. 2005; Gallant and Gilkeson 2006; Dwyer, Li et al. 2007; Geisinger, 
Astaiza et al. 2012).  
Ets1 is the prototype of the ETS family. The ETS1 protein is closely related to ETS2. 
In humans, the Ets-1 and Ets2 genes are located on two distinct chromosomes, on 
chromosome #11 and #21, respectively (Watson, McWilliams-Smith et al. 1985; 
Dittmer 2003). The Ets-1 protein sequence is highly conserved among species. It can 
be divided into six domains, A-F. The A- and B- domains are regulatory units, C- 
domain is the activation domain, the D- (or exon VII) domain and F- domain are 
regulatory domains that control the activity of E- domain, and the E- domain is the 
DNA binding Ets domain (Sharrocks 2001; Wasylyk, Schlumberger et al. 2002; 
Dittmer 2003). Ets1 harbors a conserved 85 amino acid DNA binding domain termed 
the Ets domain. The Ets1 mRNA is subject to alternate splicing to yield three 
isoforms of the protein: the full length protein p51 or p54 (based on predicted 
Figure 6. The domains of Ets1 protein, obtained from Rui-Xueleng, 
Autoimmunityreviews, 2011 
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molecular weight or on its actual migration in SDS-PAGE gels, respectively), p42, a 
protein lacking the sequences encoded in exon VII and p27, a protein lacking the 
sequences encoded in exons III-VI (Dittmer 2003; Lulli, Romania et al. 2010). The 
D- or exon VII domain comprises two regulatory units. The C-terminal unit is a part 
of an autoinhibitory module; the N- terminal sequence contains a calcium- 
responsive phosphorylation site. The two units are functionally connected as 
phosphorylation within the N- terminal sequence increases the inhibitory effect of the 
C- terminal unit (Dittmer 2003; Russell and Garrett-Sinha 2010; Hollenhorst, 
McIntosh et al. 2011). Calcium- dependent phosphorylation of the exon VII domain 
interferes with the activity of the Ets1 autoinhibitory module and decreases the 
stability of the ETS protein in T- lymphocytes (Dittmer 2003; Mellstrom, Savignac et 
al. 2008; Lulli, Romania et al. 2010). 
ETS1 is expressed in different cell types and is known to play various roles during 
both physiological and pathological conditions. ETS1 is a transcription factor that is 
highly expressed within lymphoid cells, in mice, chickens and humans (Remy and 
Baltzinger 2000; Lelievre, Lionneton et al. 2001). It is known that ETS1 regulates 
the function of immune cells including B cells, T cells, NK cells and NK T cells 
(Colucci, Caligiuri et al. 2003; Eyquem, Chemin et al. 2004; Wang, John et al. 2005; 
Choi, Geng et al. 2011; Grenningloh, Tai et al. 2011; Ramirez, Chandler et al. 2012). 
Kevin Barton has demonstrated that ETS1-deficient mice produced by gene targeting 
develop mature erythrocytes, monocytes, neutrophils, and T and B lymphocytes 
(Barton, Muthusamy et al. 1998). However, loss of ETS1 partially impairs bone 
marrow-derived B cell development in that there are fewer bone marrow derived B 
cells and they are inefficient in the pro-B to pre-B transition (Wang, John et al. 2005). 
Moreover, ETS1 knockout mice have multiple aberrations in T cell development in 
the thymus and functional responses in the periphery. Many of these early defects in 
thymocyte differentiation appear to be due to impaired pre-TCR signaling in the 
absence of ETS1 (Eyquem, Chemin et al. 2004; Higuchi, Bartel et al. 2007). In 
addition, studies have demonstrated altered cytokine production by ETS1-deficient 
CD4 and CD8 T cell subsets (Grenningloh, Kang et al. 2005; Zhu, Yamane et al. 
2010).  
Many Ets-domain transcription factors are known as nuclear targets of many 
signaling pathways (Sharrocks 2001). The transcription factor Ets2 is one of several 
transcription factors that have recently been identified as targets of Akt action in 
mammalian cells (Oikawa 2004).  
1.5.5 SGK1 
The serum & glucocorticoid inducible kinase (SGK) family exhibits structural similarity 
to Akt, though it lacks a PH domain. SGK1 is a member of the AGC family of 
serine/threonine protein kinases, originally cloned by Firestone laboratory as a 
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glucocorticoid-responsive gene from mammary tumor cells (Loffing, Flores et al. 
2006; Tessier and Woodgett 2006). Like Akt, the SGK family is encoded by three 
genes in mammalian genomes: SGK1, 2 and 3. SGK1 and 3 are ubiquitously 
expressed, while SGK2 RNA is only present in liver, kidney and pancreas, and at 
lower levels in the brain (Lang, Bohmer et al. 2006; Loffing, Flores et al. 2006). 
SGK2 and SGK3 share 80% amino acid identity with SGK1 and with each other in 
their catalytic domains. However, only SGK1 is responsive to glucocorticoids at the 
level of transcription (Arteaga, Alvarez de la Rosa et al. 2007; Pao, Bhargava et al. 
2010).  
Basically, SGKs have two domains:  C-terminal catalytic and N-terminal 
hydrophobic motif   domains (Lang, Bohmer et al. 2006; Tessier and Woodgett 
2006). Three enzymes differ in the N-terminal domain. SGK2 contains a short N 
terminus, with no discernable domain, whereas SGK3 has a longer N terminus 
comprising a phox homology domain, which is another 3´phosphorylated inositol 
phospholipid-binding domain (Tessier and Woodgett 2006; He, Lee et al. 2011). The 
catalytic domain of SGKs shares 55% identity with Akt catalytic domain. Moreover, 
similar to Akt, SGK1 is activated on phosphorylation by PDK1 activated in their turn 
by PI3K (Vanhaesebroeck and Alessi 2000; Mora, Komander et al. 2004). All three 
isoforms of SGKs require PI3K activation for function (Woodgett 2005). A 
distinguishing feature of SGK1 is its stringent stimulus-dependent regulation of its 
transcription, intrinsic kinase activity, and subcellular localization (Lang, Bohmer et 
al. 2006; Bononi, Agnoletto et al. 2011). Many extracellular and intracellular factors 
can upregulate SGK1 mRNA level, such as FSH, serum, and TGFβ (Stockand 2005; 
Lang, Bohmer et al. 2006). The SGK1 promoter region contains a glucocorticoid 
response element, a TATA box, SP-1 elements and putative binding sites for p53, 
AP-1, NFκB, and Ets-2 (Dittmer 2003; Loffing, Flores et al. 2006).  
SGK1 has been shown to foster nuclear translocation and activation of NFκB (Lang, 
Strutz-Seebohm et al. 2010). SGK1 is also involved in the regulation of many other 
Figure 7. The domain structure of SGK1 and SGK3, obtained from RE Burke - 
Pharmacology & Therapeutics, 2007 
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transcription factors, e.g. forkhead transcription factor Foxo3a and β-catenin (Brunet, 
Park et al. 2001; Dehner, Hadjihannas et al. 2008). 
Moreover, SGK1 regulates a great variety of ion channels, e.g. Na
+
 channels: 
SCN5A, ENaC, ASIC1; cation/Ca
2+
 channels: TRPV4, TRPV5, TRPV6, Orai1; K
+
 
channels: ROMK, Kv1.1–5, KCNEx/KCNQ1–5; Cl- channels: VSOAC, ClC2, 
ClCKa/bartin, CFTR; glutamate receptor GluR6 and transporters, e.g. NHE3, 
NKCC2, NCC, NaPiIIb, SMIT, GLUT1,4, SGLT1, NaDC, EAAT1–5, SN1, ASCT2, 
4F2/LAT, PepT2, and the Na
+
/K
+
-ATPase (Boehmer, Laufer et al. 2008; Boehmer, 
Palmada et al. 2008; Schuetz, Kumar et al. 2008; Gehring, Zürn et al. 2009; Krueger, 
Haerteis et al. 2009; Lang, Artunc et al. 2009; Laufer, Boehmer et al. 2009; Lang, 
Strutz-Seebohm et al. 2010; Sopjani, Kunert et al. 2010) . 
SGK1 can modulate ion channels/transporters via i) direct phosphorylation as have 
been shown e.g. for ENaC, TRPV4; ii) increasing protein abundance in the plasma 
membrane via phoshorylation and thereby inhibition of the ubiquitin ligase Nedd4-2, 
which prepares its targets for clearance from the membrane (shown for e.g. ENaC, 
SCN5a, ClCKa/bartin, ClC2, Orai1); iii) increasing channel protein abundance in 
cooperation with NHERF2 (Na
+/
H
+
 exchanger regulatory factor 2), a protein 
mediating trafficking of carriers and channels to the plasma membrane (shown for 
e.g. ROMK1, TRPV5); iv) upregulation of the transcription factor (NF-κB), which is 
required for the transcription of channel (Orai1, STIM1) (Lang and Shumilina 2012). 
Via the powerful stimulation of Orai1 and STIM1, the components of CRAC (or 
SOC) channels, which play a pivotal role in immune cell functions, SGK1 has 
recently been established as an important regulator of immune responses. In mast 
cells from SGK1-deficient mice, the decreased SOC entry is paralleled by decreased 
degranulation and a blunted anaphylactic reaction (Sobiesiak, Shumilina et al. 2009; 
Shumilina, Zemtsova et al. 2010). Along those lines, the decreased Ca
2+
 influx in 
STIM1-deficient (Baba, Nishida et al. 2007; Vig, DeHaven et al. 2007) or Orai1-
deficient (Vig, DeHaven et al. 2007)(149) mast cells similarly compromises 
degranulation, cytokine production, and anaphylactic reactions. Moreover, the recent 
study of our group has demonstrated that upon allergen-induced mast cell activation, 
SGK1-sensitive upregulation of SOC channels is required for Ca
2+
-dependent 
depolymerization of actin filaments under the plasma membrane (Schmid, Gu et al. 
2012). The depolymerization of F-actin ring provides access of mast cell granules to 
the plasma memrane (Schmid, Gu et al. 2012) and consequently, decreased 
degranulation of sgk1
-/-
 mast cells could be rescued by actin-disrupting drug 
cytochalasin B (Schmid, Gu et al. 2012). Moreover, SGK1 deficiency decreases Ca
2+
 
entry, degranulation, adhesion, and aggregation of blood platelets (Borst, Schmidt et 
al. 2012). However, nothing is known about SGK1 functions in DCs. Therefore, the 
present study explores the possible SGK1-dependent functions in mouse bone 
marrow-derived DCs. 
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2. Materials and Methods 
2.1 Materials 
2.1.1 Cell Culture 
I. Equipment 
Name Firms and Country of Origin 
Centrifuge RotiFix 32  Hettich Zentrifugen, Tuttlingen, 
Germany 
Eppendorf cups 1.5 ml  Eppendorf AG, Hamburg, 
Germany 
Eppendorf pipettes 1000 µl, 100 µl, 10 µl  Eppendorf AG, Hamburg, 
Germany 
Heraeus Incubator Thermo Electron Corporation, 
Dreieich, Germany 
Needles BD Microlance™ 3, 0.55x25 mm  Becton Dickinson Labware, 
Franklin Lakes, USA 
Neubauer counting chamber  Brand, Wertheim, Germany 
Pipetus® pipetting aid  Hirschmann Laborgeräte, 
Eberstadt, Germany 
PP-Test tubes 15, 50 ml  Greiner bio-one, Frickenhausen, 
Germany 
 Corning Incorporated, Corning 
NY, USA 
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Syringe BD 10 ml Luer-Lok™ Tip Becton Dickinson Labware, 
Franklin Lakes, USA 
Tissue Culture Dishes 60x15 mm  Becton Dickinson Labware, 
Franklin Lakes, USA 
Vortex  Genie Scientific Industries, 
Bohemia NY, USA 
II. Substance 
Name Firms and Country of Origin 
Foetal Bovine Serum (FBS) GIBCO Peprotech/Tebu, Carlsbad, 
Germany 
GMCSF mouse recombinant  GIBCO, Cölbe, Germany 
L-Glutamine  Carlsbad, Germany 
Lipopolysaccharide E.coli (LPS)  Sigma, Taufkirchen, Germany 
MEM Non-Essential Amino Acids  Invitrogen, Karlsruhe, Germany 
Penicillin-Streptomycin  Invitrogen, Karlsruhe, Germany 
Phosphate buffered saline (PBS)  GIBCO, Carlsbad, Germany 
RPMI 1640  GIBCO, Carlsbad, Germany 
Trypan blue solution 0,4%  Sigma, Taufkirchen, Germany 
β-mercaptoethanol  Invitrogen, Karlsruhe, Germany 
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2.1.2 Calcium Imaging 
I. Equipment 
Name Firms and Country of Origin 
Camera Proxitronic  Proxitronic, Bensheim, Germany 
Centrifuge RotiFix 32 Hettich  Zentrifugen, Tuttlingen, 
Germany 
Discofix® Stopcock for Infusion Therapy  B. Braun, Melsungen, Germany 
Filter Set for Fura-2  AHF Analysentechnik AG, 
Tübingen, Germany 
Filter tips 10, 100, 1000µl  Biozym Scientific, Hess. 
Oldendorf, Germany 
Filter wheel  Sutter Instrument Company, 
Novato, USA 
Infusion Regulator Dosi-Flow 10  Dahlhausen, Köln/Sürth, 
Germany 
Lambda 10-2  Sutter Instrument Company, 
Novato, USA 
Lamp XBO 75  Leistungselektronik Jena GmbH, 
Jena, Germany 
Metafluor software  Universal Imaging, 
Downingtown, USA 
Microscope Axiovert 100  Zeiss, Oberkochen, Germany 
Microscope cover glasses round, 30mm diameter, 
0.13-0.16 mm 
Karl Hecht KG, 
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Sondheim, Germany 
Neutral densitiy filters 10, 20, 40, 60%  AHF Analysentechnik AG, 
Tübingen, Germany 
Objective fluar 40x/1.3 oil  Carl Zeiss, Oberkochen, 
Germany 
Syringe BD 10 ml, Luer-Lok™ Tip  Becton Dickinson Labware, 
Franklin Lakes, USA 
Syringe BD Perfusion™ 50 ml  Becton Dickinson Labware, 
Franklin Lakes, USA 
Tissue Culture Dishes 60x10 mm  Becton Dickinson Labware, 
Franklin Lakes, USA 
Winged Needle Infusion Set  Butterfly®-Hospira 
Venisystems, Donegal Town, 
Ireland 
II. Substance 
Name Firms and Country of Origin 
Ampuwa Fresenius  KABI, Bad Homburg, Germany 
CaCl2 x 2 H2O  Carl Roth, Karlsruhe, Germany 
Recombinant Murine Exodus-2 (CCL21)  Peprotech, Hamburg, Germany 
Ethylene glycol tetraacetic acid (EGTA) Sigma, Taufkirchen, Germany 
Fura-2 AM  Invitrogen, Karlsruhe, Germany 
Glucose  Carl Roth, Karlsruhe, Germany 
HEPES Sigma, Taufkirchen, Germany 
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Immersol 518F Carl Zeiss, Göttingen, Germany 
Ionomycin Sigma, Taufkirchen, Germany 
KCl  Carl Roth, Karlsruhe, Germany 
LPS Enzo Life Sciences GmbH, Lörrach, 
Germany 
MgSO4 x 7 H2O  Sigma, Taufkirchen, Germany 
Na2HPO4 x 2 H2O Sigma, Taufkirchen, Germany 
NaCl Sigma, Taufkirchen, Germany 
Thapsigargin Invitrogen, Karlsruhe Germany 
2.1.3 Patch Clamp 
I. Equipment 
Name Firms and Country of Origin 
Borosilicate glass filaments Harvard Apparatus, March-Hugstetten, 
Germany 
DMZ puller  Zeitz, Augsburg, Germany 
EPC-9 amplifier Heka, Lambrecht, Germany 
ITC-16 Interface Instrutech, Port Washington, N.Y., USA 
Microscope Axiovert 100 Zeiss, Oberkochen, Germany 
MS314 electrical micromanipulator MW, Märzhäuser, Wetzlar, Germany 
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Pulse software Heka, Lambrecht, Germany 
II. Substance 
Name Firms and Country of Origin 
MgSO4 x 7 H2O Sigma, Taufkirchen, Germany 
Na2HPO4 x 2 H2O Sigma, Taufkirchen, Germany 
NaCl Sigma, Taufkirchen, Germany 
Poly-L-Lysine Sigma, Taufkirchen, Germany 
Silicone grease Carl Roth, Karlsruhe, Germany 
Phosphate buffered saline (PBS) Invitrogen, Karlsruhe Germany 
D-myo-inositol-1,4,5-triphosphate (IP3) Enzo, Life Sciences, Germany 
HCl Sigma, Taufkirchen, Germany 
Immersol 518F Carl Zeiss, Göttingen, Germany 
2.1.4 FACS 
I. Equipment 
Name Firms and Country of Origin 
FACS Calibur Becton Dickinson, Heidelberg, Germany 
FACS tubes, 1.3 ml, PP, round bottom Greiner bio-one, Frickenhausen, 
Germany 
II. Reagent 
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Name Firms and Country of Origin 
APC-conjugated anti-mouse CD11c,clone 
HL3 
BD Pharmingen, Heidelberg, Germany 
2',7'-dichlorodihydrofluorescein diacetate 
(DCFDA) 
Sigma, St.Luis, USA 
2.1.5 Cytokine Production 
I. Equipment 
Name Firms and Country of Origin 
Magellan™ software  Tecan Group Ltd., Männedorf, 
Switzerland 
Multi well plates; 96 well Corning Inc., Corning NY, USA 
Sunrise  Tecan Trading AG, Switzerland 
II. Kit 
Name Firms and Country of Origin 
Mouse IL-2 ELISA Set BD Pharmingen, Heidelberg, Germany 
Mouse IL-6 ELISA Set BD Pharmingen, Heidelberg, Germany 
Mouse IL-12 ELISA Set BD Pharmingen, Heidelberg, Germany 
2.1.6 Migration 
I. Equipment  
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Name Firms and Country of Origin 
BD Falcon™ Cell culture inserts for 24-
well plates. 8.0 µm pores 
BD Falcon, Heidelberg, Germany 
BD Falcon™ cell culture insert 
companion plates (24-well, BD cat. no. 
353504) 
BD Falcon, Heidelberg, Germany 
Carl Zeiss Microscopy LSM 700 Carl Zeiss, München, Germany 
II. Reagent  
Name Firms and Country of Origin 
CCL21 Peprotech/Tebu, Cölbe, Germany 
CXCL12 Peprotech/Tebu, Cölbe, Germany 
Xestospongin C, Xestospongia sp Enzo Life Sciences GmbH, Lörrach, 
Germany 
Paraformaldehyde Sigma, Taufkirchen, Germany 
ProLong® Gold Antifade Reagent with 
DAPI 
Invitrogen, Darmstadt Germany 
2.1.7 Western Blotting and Nuclear Fractionation 
I. Equipment 
Name Firms and Country of Origin 
Agarose gel electrophoresis chamber BioRad, München, Germany 
Centrifuge 5415R Eppendorf, Hamburg, Germany 
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Densitometer Quantity One BioRad, München, Germany 
GE Healthcare film GE Healthcare, München, Germany 
Nitrocellulose membrane GE Healthcare, München, Germany 
II. Reagent 
Name Firms and Country of Origin 
Acrylamide/bisacrylamide Carl Roth, Karlsruhe, Germany 
Cell lysis buffer 10x Cell Signaling Technology, Frankfurt, 
Germany 
Complete Protease Inhibitor Cocktail 
Tablets 
Roche, Mannheim, Germany 
Detection reagent GE Healthcare, München, Germany 
Glycine Sigma, Taufkirchen, Germany 
Loading buffer (4x) Carl Roth, Karlsruhe, Germany 
Milk powder Carl Roth, Karlsruhe, Germany 
peqGOLD Protein-Marker IV Peqlab, Erlangen, Germany 
peqGOLD Protein-Marker V Peqlab, Erlangen, Germany 
Sodium dodecyl sulfate (SDS) Sigma, Hannover, Germany 
TEMED Carl Roth, Karlsruhe, Germany 
Tween® 20 Carl Roth, Karlsruhe, Germany 
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2.1.8 Real Time-PCR 
I. Equipment 
Name Firms and Country of Origin 
BZO Seal Film Biozym biotech trading GmbH 
CFX96 Real Time System BioRad, München, Germany 
Low Profile 96 Well PCR Plate PEQLAB Biotechnologie GMBH, 
Erlangen, Germany  
UV Cuvette Eppendorf AG, Hamburg, Germany 
 
II. Reagent / Kit 
Name Firms and Country of Origin 
2-Propanol (Isopropanol) Sigma, Taufkirchen, Germany 
Chloroform Carl Roth, Karlsruhe, Germany 
DEPC water Promega, Mannheim, Germany 
dNTP mix Promega, Mannheim, Germany 
Ethanol 99.7% VWR, Darmstadt, Germany 
GoTaq® qPCR Master Mix Promega, Mannheim, Germany 
peqGOLD TriFast PEQLAB Biotechnologie GMBH, 
Erlangen, Germany 
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Primers Invitrogen, Darmstadt Germany 
Transcriptor High Fidelity cDNA 
Synthesis Kit 
Roche, Mannheim, Germany 
2.2 Solutions 
2.2.1 Cell Culture Medium 
Normal Medium 
Substance  (RPMI 1640 500ml) 
FBS 10% 
Penicillin Streptomycin 1% 
Glutamine 1% 
Nonessential amino acids 1% 
β-mercaptoethanol 0.05% 
Medium for Silencing 
Substance  (RPMI 1640 500ml) 
Penicillin Streptomycin 1% 
Glutamine 1% 
Nonessential amino acids 1% 
β-mercaptoethanol 0.05% 
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2.2.2 Intracellular Calcium Imaging 
Chemical and Biological Reagents 
Standard HEPES Solution  
Substance [mmol/L] 
NaCl 125 
KCl 5 
MgSO4x7H2O 1.2 
HEPES 32.2 
Na2HPO4x2H2O 2 
CaCl2x2H2O 2 
Glucose 5 
pH 7.4 (NaOH); H2O (at the 37 ℃) 
Ca
2+
 Free Solution  
Substance [mmol/L] 
NaCl 125 
KCl 5 
MgSO4x7H2O 1.2 
HEPES 32.2 
  
36 
Na2HPO4 x2H2O 2 
EGTA 0.5 
Glucose 5 
pH 7.4 (NaOH); H2O (at the 37 ℃) 
2.2.3 Patch Clamp – Pipette Solutions 
Pipette Solution [mmol/L] 
NaCl 35 
CsCl 120 
EGTA 10 
HEPES 10 
IP3 0.04 
pH 7.2 (CsOH); H2O (at the 20 ℃) 
Bath Solution [mmol/L] 
NaCl 140 
KCl 5 
CaCl2 10  
Glucose 20 
HEPES 10 
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pH 7.4 (NaOH); H2O (at the 20 ℃) 
2.2.4 FACS 
FACS Buffer 
PBS 
0.1 % heat-inactivated FBS 
Cytokine Production 
Coating Buffer 
0.2 M sodium phosphate  
pH 6.5 (HCl); H2O (at room temperature) 
Assay Diluent 
1x PBS 
heat-inactivated FBS 10 % 
Stop Solution 
2 M H2SO4 
2.2.5 Western Blotting and Nuclear Fractionation 
Running Buffer 
Tris 25 mM 
Glycine 250 mM 
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SDS 0,1 % 
Transfer Buffer 
Tris 25 mM 
Glycine 192 mM 
Methanol 20 % 
pH 8.3 (HCl); H2O (at room temperature) 
Wash Buffer (TBS-T) 
Tris 50mM 
NaCl 150mM 
Tween-20 0.05 % 
pH 7.4 (HCl); H2O (at room temperature)  
Nuclear Fractionation Buffer A 
10 mM HEPES 
1.5 mM MgCl2 
10 mM KCl 
0.5 mM DTT 
0.05% NP40 
pH 7.9 (HCl); H2O (at room temperature) 
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Nuclear Fractionation Buffer B 
5 mM HEPES  
1.5 mM MgCl2 
0.2 mM EDTA 
0.5 mM DTT 
26% glycerol (v/v) 
pH 7.9 (HCl); H2O (at room temperature) 
2.3 Animals 
All animal experiments were conducted according to the German law for the welfare 
of animals and were approved by local authorities.  
Akt2-deficient mice (akt2
-/-
) and their wild type littermates (akt2
+/+
) as well as 
SGK1- deficient mice (sgk1
-/-
) and their wild type littermates (sgk1
+/+
) were used in 
the present study. Male and female mice were studied at the age of 6-12 weeks. 
Origin of the akt2
-/-
 mice, breeding and genotyping were described previously(Cho, 
Mu et al. 2001). Knockout mice were generated with a targeted disruption in the Akt2 
locus by homologous recombination. The targeting vector was designed to insert 
LoxP sites flanking the sequence containing the coding exons 4 and 5. Mice 
harboring the targeted allele were identified by Southern blotting and were mated to 
transgenic mice expressing Cre recombinase driven by a 6-kb 59-flanking sequence 
from the Brn/Pou3f4 gene to cause germ-line excision of exons 4 and 5. The progeny 
carrying both the Cre transgene and the targeted allele were mated with wild-type 
mice to obtain offspring in which the Cre transgene was segregated away and the 
targeted allele was excised, as determined by the PCR and Southern blotting, 
respectively. These mice were mated inter se to produce offspring with homozygous 
deletions of Akt2. 
Origin of the sgk1
-/-
 mice, breeding and genotyping were described previously (Wulff, 
Vallon et al., 2002).  
A conditional targeting vector was generated from a 7-kb fragment encompassing the 
entire transcribed region on 12 exons. The neomycin resistance cassette was flanked 
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by two loxP sites and inserted into intron 11. Exons 4-11, which code for the sgk1 
domain, were ―floxed‖ by inserting a third loxP site into intron 3. Targeted R1 ES 
cells were transiently transfected with Cre recombinase. A clone with a 
recombination between the first and third loxP site (type I recombination) was 
injected into C57BL/6 blastocytes. Male chimeras were bred to 129/SvJ females. 
Heterozygous sgk1-deficient mice were backcrossed to 129/SvJ wild-type mice for 
two generations and then intercrossed to generate homozygous sgk1
–/–
 and sgk1
+/+
 
littermates (Wulff, Vallon et al., 2002). The animals were genotyped by PCR using 
standard methods.  
2.4  Methods 
2.4.1 Culture of Bone Marrow Dendritic Cells 
Dendritic cells (DCs) were isolated from the mouse bone marrow as described 
previously (Matzner, Zemtsova et al. 2008; Xuan, Shumilina et al. 2009). Briefly, 
bone marrow derived cells were flushed out of the cavities from the femur and tibia 
with PBS. Cells were then washed twice with RPMI and seeded out at a density of 2 
x 10
6 
cells per 60 mm dish. Cells were cultured for up to 9 days in RPMI 1640 
(GIBCO, Carlsbad) containing: 10% FCS, 1% penicillin/streptomycin, 1% glutamine, 
1% non-essential amino acids (NEAA) and 0.05% β-mercaptoethanol. Cultures were 
supplemented with GM-CSF (35 ng/mL, Immunotools) and fed with fresh medium 
containing GM-CSF on days 3 and 6. Experiments were performed on days 7-9. 
Immature and mature DCs were used in the present study. DC maturation was 
induced by treating the cells with lipopolysaccharides (LPS from E. coli, 100 ng/ml, 
48h or 1 µg/ml, 24 h, Enzo Life Sciences, Lausen, Switzerland). 
2.4.2 Isolation of Splenic DCs 
Dendritic cells were isolated from the spleen of 8-12 weeks old mice accoriding to the 
protocol of Stagg et al. (Stagg, Burke et al., 2001). Briefly, single-cell suspensions were 
prepared by pressing mouse spleen through a gauze cell strainer (BD Pharmingen, 
Heidelberg, Germany) and washing in RPMI 1640 (GIBCO, Carlsbad, Germany) containing: 
10 % FCS, 1 % penicillin/streptomycin, 1 % glutamine, 1 % non-essential amino acids 
(NEAA) and 0.05 % β-mercaptoethanol. After overnight incubation nonadherent cells were 
collected and DCs were purified by centrifugation over a 13.7% (w/v) metrizamide 
discontinuous gradient. 
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2.4.3 Intracellular Calcium Imaging 
To determine cytosolic Ca
2+
 concentration, the cells were loaded with Fura-2/AM (2 
µM, Molecular Probes, Goettingen, Germany) for 15 min at 37°C. Fluorescence 
measurements were carried out with an inverted phase-contrast microscope (Axiovert 
100, Zeiss, Oberkochen, Germany). Cells were excited alternatively at 340 or 380 
nm and the light was deflected by a dichroic mirror into either the objective (Fluar 
40×/1.30 oil, Zeiss, Oberkochen, Germany) or a camera (Proxitronic, Bensheim, 
Germany). Emitted fluorescence intensity was recorded at 505 nm and data 
acquisition was accomplished by using specialized computer software (Metafluor, 
Universal Imaging Downingtown, USA). As a measure for the increase of cytosolic 
Ca
2+
 concentration, the slope and peak of the changes in the 340/380 nm ratio were 
determined for each experiment.  
Intracellular Ca
2+
 was measured prior to and following addition of CXCL12 (300 
ng/ml) or CCL21 (75 ng/ml) to the Ringer solution (see below). Alternatively, the 
Ca
2+
 release was measured following addition of MgATP (100 µM, Alfa Aesar 
GmbH & Co KG, Germany) to the Ca
2+
-free solution (see below). 
In order to measure SOC entry, changes in cytosolic Ca
2+ 
were monitored upon 
depletion of the intracellular Ca
2+
 stores. Experiments were carried out prior to and 
during exposure of the cells to Ca
2+
-free solution (see below). In the absence of Ca
2+
, 
the intracellular Ca
2+
 stores were depleted by inhibition of the vesicular Ca
2+
 pump 
by thapsigargin (1 µM, Molecular Probes). Re-addition of Ca
2+
 allowed assessing the 
store-operated Ca
2+
 entry.  
2.4.4 Whole-cell Patch Clamp 
Patch clamp experiments were performed at room temperature in voltage clamp, fast-
whole-cell mode according to Hamill et al. (Hamill, Marty et al. 1981). The cells 
were continuously superfused through a flow system inserted into the dish. The bath 
was grounded via a bridge filled with NaCl Ringer solution. Borosilicate glass 
pipettes (2-4 MΩ tip resistance; GC 150 TF-10, Harvard Apparatus, UK) heat 
polished with a microprocessor-driven DMZ puller (Zeitz, Augsburg, Germany) 
were used in combination with a MS 314 electrical micromanipulator (MW, 
Märzhäuser, Wetzlar, Germany). The currents were recorded by EPC-9 amplifier 
(Heka, Lambrecht, Germany) using Pulse software (Heka) and an ITC-16 Interface 
(Instrutech, Port Washington, N.Y., USA). For ICRAC measurements whole-cell 
currents were elicited by 200 ms square wave voltage pulses from -50 to +50 mV in 
10 mV steps delivered from a holding potential of -30 mV. Alternatively, the 
currents were recorded with 200 ms voltage ramps from -50 to +50 mV. Leak 
currents determined as the currents at the very beginning of each experiment 
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immediately after reaching the whole-cell mode were subtracted. The currents were 
recorded with an acquisition frequency of 10 kHz and 3 kHz low-pass filtered. The 
liquid junction potential ΔE between the CsCl-based pipette and the NaCl-based bath 
solutions estimated according to Barry and Lynch (Barry and Lynch 1991) was 1 mV. 
The data were not corrected for ΔE.  
DCs were superfused with a bath solution containing (in mmol/l): 140 NaCl, 5 KCl, 
10 CaCl2, 20 glucose, 10 HEPES/NaOH, pH 7.4. The patch clamp pipettes were 
filled with an internal solution containing (in mmol/l): 120 CsCl, 35 NaCl, 10 EGTA, 
10 HEPES/CsOH, 0.04 inositol 1,4,5-trisphosphate (Ins(1,4,5)P3, Enzo Life 
Sciences), pH 7.4.  
2.4.5 Migration Assay 
For migration assays transwell inserts were used with a pore diameter size of 8 µm. 
The transwells were placed in a 24-well cell culture plate containing cell culture 
medium (500 µl) with or without either CXCL12 (50 ng/ml, Peprotech, for immature 
DCs) or CCL21 (25 ng/ml, Peprotech, for mature DCs) in the lower chamber. The 
upper chambers were filled with 500 µl cell culture medium containing immature or 
LPS (1 µg/ml, 24 h) - matured DCs either untreated or treated with IP3R inhibitor 
Xestospongin C (5 µM, Enzo Life Sciences, Lausen, Switzerland) for 3h in a 
concentration of 1 x 10
5
 cells/ml. The chamber was placed in a 5% CO2 37°C 
incubator for 3h. In the following step, the transwells were placed in 4% PFA for 
overnight incubation in 4°C, to allow the cells to fix on the membrane. Unattached 
cells were gently removed with cotton swab, the membrane was then mended on a 
slide and stained with ProLong® Gold antifade reagent with DAPI (Invitrogen). 
Cells from five representative areas of each membrane were counted. 
2.4.6 Cytokine Production 
IL-12, IL-6, IL-2 and TNFα concentrations in culture supernatants from DCs treated 
with LPS (1 µg/ml, 24 h, for IL-6 measurements), LPS (1 µg/ml, 18 h, for IL-2 
measurements), LPS (100 ng/ml, 48 h, for IL-12 measurements), or LPS (1 µg/ml, 4 
h, for TNFα measurements) were determined by using OptEIA ELISA kit (BD 
Pharmingen) according to the manufacturer's protocol. 
2.4.7 DC Phagocytosis Assay 
DCs (10
6
 cells/ml) were suspended in prewarmed serum-free RPMI 1640 medium, 
pulsed with FITC-conjugated dextran (Sigma-Aldrich, Taufkirchen, Germany) at a 
final concentration of 1 mg/ml and incubated for 3h at 37°C. Uptake was stopped by 
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adding ice-cold PBS. Then the cells were washed three times with ice cold PBS 
supplemented with 5% FCS and 0.01% sodium azide before FACS analysis. DCs 
were analyzed for the uptake of FITC-dextran. 
2.4.8 Western Blotting 
Protein lysates were separated by SDS-PAGE 10% gel electrophoresis and 
transferred onto nitrocellulose membrane. Membrane containing the immobilized 
proteins was incubated for 1 hour at room temperature with 10% non-fat milk in 
Tris-buffered saline-0.1% Tween 20 (TBS-T), followed by overnight incubation (4°C) 
with IP3R2 primary antibody (1:750; Santa Cruz,), rabbit polyclonal ETS1 (1:200, 56 
kDa, Abcam, ), NDRG1 (1:1000), NFκBp65(1: 1000), rabbit monoclonal GAPDH 
(1:1000, 37 kDa, Cell Signaling). The following day membrane was washed 3 times 
in TBS-T and incubated for 1 h at room temperature with anti-rabbit (1:3000, Cell 
Signalling) or anti-goat (1:3000, Santa Cruz) secondary antibody and washed again 
in TBS-T. For detection, membrane was blotted with ECL reagent (GE Healthcare), 
exposed to X-ray film (GE Healthcare) and developed. 
2.4.9 Nuclear Fractionation 
Prepare 1 ml of buffer A with added cocktail of usual inhibitors (Roche). Twenty 
million transfected cells were harvested and washed twice with ice-cold PBS 
followed by resuspending the cell pellet in 500 μl of buffer A, leave on ice for 10 
min. Centrifuge at 4°C at 3000 rpm for 10 min. Remove supernatant and keep it (this 
will contain everything except large plasma membrane pieces, DNA, nucleoli). On 
ice resuspend pellet in 374 μl of buffer B and add 26 μl of 4.6 M NaCl. Leave on ice 
for 30 min. Centrifuge at 24,000 g for 20 min at 4°C. Aliquot supernatant, remove 10 
μl for Bradford assay and processed on SDS-PAGE for westernblotting. 
2.4.10 Real-Time PCR 
Total RNA was extracted from mouse DCs in Tri-Fast (Peqlab, Erlangen, Germany) 
according to the manufacturer‘s instructions. After DNAse digestion reverse 
transcription of total RNA was performed using Transcriptor High Fidelity cDNA 
Synthesis Kit (Roche Diagnostics, Penzberg, Germany). Real-Time Polymerase 
chain reaction (RT-PCR) amplification of the respective genes were set up in a total 
volume of 20 µl using 2 μg of cDNA, 500 nM forward and reverse primer and 2 X 
GoTaq® Mast Mix (Promega, Mannheim, Germany) according to the manufacturer's 
protocol. Cycling conditions were as follows: initial denaturation at 95°C for 2 min, 
followed by 39 cycles of 95°C for 15 s, 58°C for 15 s and 68°C for 20 s. For the 
amplification the following primers were used (5`->3`orientation): 
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Table 2. RT-PCR primers sequences 
Name Forward sequence (5´->3´) Reverse sequence (5´->3´) 
Akt1 CAGCACCGGTTCTTTGCC CAGTCTCAGAGGTGACCTGGG 
Akt2 AGTGATGGAGCCACCATGA
A 
CCACTGCTCGCCCATAGTC 
Akt3 CCGCTCGTTGTCCATGC TTTTGATGAAGAATTACAGCTCA
GA 
IP3R1 AAGCGGATGGACCTGGTGT
TAGAACTG 
AATTTGTGCTGTGTGCTTCGCGTA
GAACT 
IP3R2 CTGTTCTTCTTCATCGTCAT
CATCATCG 
GAAACCAGTCCAAATTCTTCTCC
GTGA 
IP3R3 CTTCTTTATCGTCATCATCA
TCGTGTTG  
AGGTTCTTGTTCTTGATCATCTGA
GCCA 
RyR1 TGGGGCACTACAATAACTT
C 
AGCAGAATGACGATAACGAA 
RyR2 CACAGACAATTCCTTCCTC
TACCTA 
AACACCTCTCTTGGTACATCTTCC 
RyR3 AGGTTCCTTGCTCTGTTTGT TGCTTTGGCCTCTTCTACTG 
Ets1 GATATCCTGTGGGAGCATC
TAGAGATC 
CAGCTGGATCGGCCCACTTCCTG
TGTAG 
Ndrg1 ACCCTGAGATGGTAGAGGG
TCTC 
CCAATTTAGAATTGCATTCCACC 
Tbp CACTCCTGCCACACCAGCT
T 
TGGTCTTTAGGTCAAGTTTACAG
CC 
Specificity of the PCR product was confirmed by analysis of melting curves. 
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Real-time PCR amplifications were performed on a CFX96 Real Time System (Bio-
Rad). All experiments were done in duplicates. Amplification of housekeeping gene 
Tbp (TATA binding protein) was performed to standardize the amount of sample 
RNA. Relative quantification of gene expression was achieved with the Ct method 
(where Ct is threshold cycle). In addition, PCR products were analysed by agarose 
gel electroporesis. 
2.4.11 Immunoprecipitation 
The cells were washed twice in ice-cold phosphate-buffered saline. The cell pellets 
were transfered into a cell lysis buffer (Cell Signaling) containing complete protease 
inhibitor mixture (Roche Applied Science). Lysates were washed with 50µl of 
protein A/G PLUS agarose beads (Santa Cruz) and then the supernatants were 
incubated overnight with Phospho-Akt Substrate (RXRXXS*/T) antibody. The 
supernatant and the antibody mixture was incubated with protein A/G PLUS agarose 
beads that were washed three times in cell lysis buffer, incubated at 37°C for 1 hour, 
then heated upto 95 °C for 5 min, and processed on SDS-PAGE for immunoblotting.  
2.4.12 Gene Silencing 
Specific siRNA sequences for Ets1 (Santa Cruz), negative control (Control siRNA, 
Santa Cruz) and siRNA sequences for Ndrg1 (Invitrogen) and negative control 
(Invitrogen) were synthesized and annealed by the manufacturer. siRNA transfection 
was carried out using the GeneSilencer siRNA transfection reagent (Genlantis, San 
Diego, CA,USA). 4 x 10
6
 cells were washed and plated in 6-well plates in 2 ml of 
serum-free RPMI 1640. The siRNA and the negative control (1000 ng/ml) were 
incubated with GeneSilencer reagent following the manufacturer‘s protocol. 
Transfection mixture was then added to the wells and incubated overnight. The 
efficiency of silencing was assessed with RT-PCR and western blotting. 
2.4.13 Statistical Analysis 
Data are provided as means ± SEM, n represents the number of independent 
experiments. Differences were tested for significance using Student‘s unpaired two-
tailed t-test or ANOVA. P<0.05 was considered statistically significant.
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3. Result 
Part1. Akt2- and ETS1-dependent Expression of IP3 Receptor 2 is Required for 
Dendritic Cell Migration 
3.1 Differentiation and Maturation of Bone Marrow 
Derived DCs 
DCs were isolated from gene targeted mice lacking functional Akt2 (akt2
-/-
) and their 
wild type littermates (akt2
+/+
).  
 
Figure 8 Differentiation, maturation and cytokine production of bone marrow 
derived dendritic cells (DCs) from akt2+/+ and akt2-/- mice 
A. Original dot plots of CD11c+CD86+ (above) and CD11c+MHC II+ (below) DCs at 
the basal level (control, 1st and 2d panels) and stimulated with LPS (LPS, 1 µg/ml, 
24 h, 3d and 4th panels) from akt2+/+ (1st and 3d panels) and akt2-/- (2d and 4th 
panels) mice. Numbers depict the percent of cells in the respective quadrants. 
B. Arithmetic means ± SEM (n =7) of the percentage of CD11c+CD86+ (left) and 
CD11c+MHC II+ (right) DCs under control and 24 h after LPS stimulation in primary 
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cultures from akt2+/+ (open bars) and akt2-/-  (closed bars) mice. *** (p<0.001), 
ANOVA. 
As illustrated in Fig 8, the surface abundance of both, the costimulatory molecule 
CD86 and antigen-presenting molecule MHC II, was similar on CD11c
+
 DCs from 
akt2
+/+
 and akt2
-/-
 mice. In both genotypes, exposure for 24 hours to bacterial 
lipopolysaccharides (LPS, 1 µg/ml) resulted in a significant increase of the 
CD11c
+
CD86
+
 population. Following LPS treatment, the abundance of CD86 and 
MHC II was still similar in DCs from akt2
+/+
 and akt2
-/-
 mice (Fig. 8A, B). The 
release of interleukin 6 (IL-6) and 12 (IL-12) was again similar in LPS-matured DCs 
from akt2
+/+
 and akt2
-/-
 mice (Fig. 8C). 
3.2 Impaired Migration of akt2
-/-
  DCs  
Migratory capacity of immature akt2
-/-
 DCs in response to the CXCL12 chemokine 
as well as spontaneous migration was not different from akt2
+/+
 DCs (Fig. 9A). 
However, in contrast to LPS-matured akt2
+/+
 DCs, LPS-matured akt2
-/-
 DCs failed to 
significantly enhance migration in response to the chemokine CCL21 (25 ng/ml) (Fig. 
9B).   
 
Figure 9. Impaired migration of LPS-matured akt2-/- DCs 
A.-B. Arithmetic means ± SEM (n =11-18) of spontaneous migration and migration 
in response to either CXCL12 (50 ng/ml, 3h, immature DCs, A) or CCL21 (25 ng/ml, 
3h, LPS (1 µg/ml, 24h)-matured DCs, B) of akt2+/+ (open bars) and akt2-/- (closed 
bars) DCs. * (p<0.05), ** (p<0.01), ANOVA. 
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3.3 Reduced CCL21-dependent Increase of [Ca
2+
]i in  
akt2
-/-
 DCs 
Fura2-fluorescence has been employed to determine, whether the difference in 
migratory activity of LPS-matured akt2
-/-
 DCs was paralleled by the differences in 
the regulation of cytosolic Ca
2+
 concentrations ([Ca
2+
]i). As illustrated in Fig. 10, 
both slope and peak of CCL21 (75 ng/ml)-induced increase of [Ca
2+
]i was 
significantly less pronounced in LPS-matured DCs from from akt2
-/-
 mice than in 
DCs from akt2
+/+
 mice. Chemokine-induced increase of [Ca
2+
]i is known to be due to 
the release of Ca
2+
 from intracellular stores followed by the store operated Ca
2+
 entry 
(SOCE) (Barbet, Demion et al. 2008; Nurbaeva, Schmid et al. 2012). 
 
Figure 10. Diminished CCL21-induced increase in intracellular Ca2+ concentration in 
akt2-/- DCs 
A. Representative original tracings showing the Fura-2 fluorescence ratios 
(340/380 nm) in LPS (1 µg/ml)-matured akt2+/+ DCs (open squares) and akt2-/- DCs 
(closed circles) prior to and following acute addition of CCL21 (75 ng/ml; white 
arrow). For quantification of Ca2+ entry the slope (∆ ratio/s) and the peak (∆ ratio) 
of the fluorescence ratio were calculated by linear regression. 
B. Mean (± SEM) of peak (left) and slope (right) of the change in Fura-2 
fluorescence following addition of CCL21 (75ng/ml) to mature akt2+/+ (n = 50, 
open bars) and akt2-/- (n = 40, closed bars) DCs. ** (p<0.01), two-tailed unpaired t-
test. 
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3.4 Reduced Ca
2+
 Release and Store-operated Ca
2+
 Entry 
in LPS-matured akt2
-/-
 DCs 
Therefore, further experiments addressed the impact of Akt2 on Ca
2+
 release from 
intracellular stores and on SOCE in LPS-matured DCs. As indicated in Fig. 11, the 
addition of sarcoendoplasmatic reticulum Ca
2+
 ATPase (SERCA) inhibitor 
thapsigargin (1 µM) in the absence of extracellular Ca
2+
 was followed by an increase 
of [Ca
2+
]i, reflecting release of Ca
2+
 from intracellular stores. The slope and the peak 
of the intracellular Ca
2+
 release were significantly decreased in mature DCs from 
akt2-/- mice (Fig. 11B). The readdition of extracellular Ca
2+
 in the continued 
presence of thapsigargin resulted in a rapid increase of [Ca
2+
]i, reflecting SOCE. 
Both, peak and slope of SOCE were significantly higher in DCs from akt2
+/+
 mice 
than in DCs from akt2
-/- 
mice. Release of Ca
2+
 induced by physiological IP3 
formation could be assessed through the stimulation of DCs via P2Y receptors with 
low concentrations of ATP (Pellegatti, Falzoni et al. 2005). Accordingly, ATP(100 
µM)-induced release of Ca
2+
 (measured in the absence of extracellular Ca
2+
) was 
lower in LPS-matured akt2
-/- 
than in akt2
+/+
 DCs (Fig. 11C). 
3.5 Impaired CRAC Channel Activity in LPS-matured 
akt2
-/-
 DCs 
Reduced SOCE in mature akt2
-/-
 DCs could be confirmed by whole cell patch clamp 
recordings. As illustrated in Fig. 12, the Ca
2+
 release activated Ca
2+
 current ICRAC 
triggered by IP3–induced Ca
2+
 store depletion was significantly higher in LPS-
matured DCs from akt2
+/+
 mice than in akt2
-/- 
DCs.  
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Figure 11.  Reduced Ca2+ Release and Store-operated Ca2+ Entry in akt2-/- DCs 
A. Representative tracing showing the Fura-2 fluorescence ratio in Fura-2/AM 
loaded LPS (1 µg/ml)-matured akt2+/+ and akt2-/- DCs. Experiments were carried 
out prior to and during exposure to Ca2+-free bath solution. Where indicated, 
thapsigargin (1 µM) was added to the Ca2+-free bath solution and the release of 
Ca2+ from the stores was assessed. Readdition of extracellular Ca2+ in the presence 
of thapsigargin reflects the entry of Ca2+ through the SOC channels.  
B. Arithmetic means (± SEM) of the slope (right) and the peak (left) of the change 
in Fura-2 fluorescence following addition of thapsigargin (1 µM) in the absence 
(upper bars) and in the presence (lower bars) of extracellular Ca2+ to mature 
akt2+/+ (n=117, open bars) and akt2-/- (n=75, closed bars) DCs. *** (p<0.001), two-
tailed unpaired t-test. 
C. Representative tracing showing the Fura-2 fluorescence ratio in LPS (1 µg/ml)-
matured akt2+/+ and akt2-/- DCs prior to and following addition of ATP (100 µM) to 
the Ca2+-free bath solution. 
D. Arithmetic means (± SEM) of the slope (right) and the peak (left) of the change 
in Fura-2 fluorescence following addition of ATP (100 µM) in the absence of 
extracellular Ca2+ to LPS (1 µg/ml)-matured akt2+/+ (n=242, open bars) and akt2-/- 
(n=250, closed bars) DCs. * (p<0.05), two-tailed unpaired t-test. 
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Figure 12. Impaired currents through store-operated Ca2+ channels in akt2-/- DCs 
A. Mean current-voltage (I/V) relationships of currents activated by 40 µM IP3 
normalized to cell capacitance in LPS (1 µg/ml)-matured akt2+/+ (n=11) and akt2-/- 
(n=15) DCs. * (p<0.05), two-tailed unpaired t-test.  
B. Mean whole-cell conductance of inward currents (± SEM) calculated by linear 
regression of I/V curves shown in (A) between -50 and -10 mV in akt2+/+ (n = 11, 
open bars) and akt2-/- (n=15, closed bars) DCs. * (p<0.05), two-tailed unpaired t-
test. 
3.6 Impaired Transcript Level and Protein Abundance of 
IP3R2 in Mature akt2
-/-
 DCs 
Impaired Ca
2+
 release, SOCE and ICRAC in akt2
-/- 
DCs could have resulted from Akt2 
sensitivity of the Ca
2+
 release pathways such as inositoltrisphosphate receptors IP3R1-3 or 
the ryanodine receptor RyR1. As illustrated in Fig. 13A, transcript levels of IP3R1, IP3R3 
and RyR1 were similar in immature akt2
+/+
 and akt2
-/- 
DCs, whereas the transcript abundance 
of IP3R2 was significantly higher in akt2
+/+
 DCs than in akt2
-/- 
DCs. Stimulation of akt2
+/+
 
DCs with LPS (1 µg/ml) resulted in a transient upregulation of IP3R2 transcript abundance 
within 1h in akt2
+/+
 DCs, an effect significantly impaired in akt2
-/- 
DCs (Fig. 13B). 
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Western blot analysis was employed to elucidate whether the differences in transcript levels 
were paralleled by similar differencs in IP3R2 protein abundance. Prior to maturation, the 
IP3R2 protein abundance was similar in akt2
+/+
 and akt2
-/- 
DCs. LPS (1 µg/ml, 24 h)-induced 
maturation resulted in a significant increase of IP3R2 protein abundance in akt2
+/+
 DCs, but 
not in akt2
-/- 
DCs. Accordingly, following treatment with LPS, the IP3R2 protein abundance 
was significantly higher in DCs from akt2
+/+
 mice than in DCs from akt2
-/- 
mice (Fig.13C). 
 
Figure 13. Transcript levels of IP3R1, IP3R3 and RyR1 in immature and treated with 
LPS-1H akt2+/+ and akt2-/- DCs. 
A. Arithmetic means (± SEM, n=3) of the abundance of mRNA encoding the IP3 
receptors: IP3R1, IP3R2, and IP3R3 as well as of the ryanodine receptor RyR1 in 
immature akt2+/+ and akt2-/- DCs as assessed by real-time PCR using Tbp mRNA as 
a reference gene. * (p<0.05), two-tailed unpaired t-test. 
B. Arithmetic means (± SEM, n=7-13) of the abundance of mRNA encoding IP3R2 in 
akt2+/+ and akt2-/- DCs unstimulated (LPS, 0h) and stimulated with LPS (1 µg/ml, 1h 
and 4h). * (p<0.05), ** (p<0.01), *** (p<0.001), ANOVA. 
C. Original representative Western blot of whole cell lysate protein of IP3R2 
(upper panel) and GAPDH (lower panel) in LPS (1 µg/ml, 24 h)-matured akt2+/+ and 
akt2-/- DCs.   
D. Arithmetic means ± SEM (n =11-15) of IP3R2/GAPDH ratio in immature and LPS 
(1 µg/ml, 24 h)-matured akt2+/+ and akt2-/- DCs. *(p<0.05), ANOVA. 
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3.7 Xestospongin C Inhibits the Migration of LPS-
matured akt2
+/+
 and akt2
-/-
 DCs  
To further address the functional significance of Akt2 sensitive IP3R2 regulation, migratory 
capacity was tested in LPS-matured DCs from akt2
+/+
 and akt2
-/- 
mice in the absence and 
presence of IP3R inhibitor xestospongin C (5 µM). Xestospongin C significantly decreased 
the migratory activity of CCL21-treated LPS-matured akt2
+/+
 DCs and abrogated the 
differences in migratory activity between DCs from akt2
+/+
 and akt2
-/- 
mice. CXCL12-
induced migration of immature DCs was also sensitive to xestospongin C, however, no 
significant difference between akt2
-/- 
and akt2
+/+
 DCs was observed (Fig.14).  
Figure 14. Migration of akt2+/+ and akt2-/- DCs in the absence and presence of IP3R 
iInhibitor Xestospongin C 
Arithmetic means ± SEM (n = 5-25) of spontaneous migration and migration in 
response to either CXCL12 (50 ng/ml, 4h, immature DCs, A) or CCL21 (25 ng/ml, 4h, 
LPS (1 µg/ml, 24h)-matured DCs, B) of akt2+/+ (open bars) and akt2-/- (closed bars) 
DCs in the absence or in the presence of the IP3R inhibitor Xestospongin C (Xc, 5 
µM, 3h) *(p<0.05), **(p<0.01), ***(p<0.001), ANOVA; #( p<0.05), two-tailed 
unpaired t-test. 
3.8 Impaired Expression of the Transcription Factor 
ETS1 in akt2 
-/-
 DCs 
PKB/Akt is known to phosphorylate IP3R, reducing its sensitivity to IP3 and diminishing 
Ca
2+
 release (Szado, Vanderheyden et al. 2008). In contrast, reduced IP3R2 transcript level 
and protein abundance in akt2
-/-
 DCs in the present study suggest that in DCs Akt2 
upregulates IP3R2 on a transcriptional level. However, we examined the phosphorylation 
status of IP3R2 by immunoprecipitating the lysates with a phosphospecific antibody that 
detects the consensus Akt phosphorylation sequence (RXRXX(S/T)) and immunoblotting 
with IP3R2-specific antibody (Fig. 15A). IP3R2 was phosphorylated in immature as well as 
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in LPS-matured DCs, however no significant difference was detected between akt2
+/+
 and 
akt2
-/-
 DCs. 
It has been shown that expression of IP3R3 in CD4 T cells requires the ETS1 
transcription factor (Nagaleekar, Diehl et al. 2008). In ETS1-deficient CD4 T cells 
the level of IP3R2 protein was also reduced (Nagaleekar, Diehl et al. 2008). 
Moreover, activated Akt has been shown to lead to increased Ets1 transcription 
(Lavenburg, Ivey et al. 2003). Therefore we next examined the transcript level of 
Ets1 in akt2
-/-
 and akt2
+/+
 DCs. In immature akt2
-/-
 DCs the transcript abundance of 
Ets1 was significantly impaired compared to akt2
+/+
 DCs (Fig. 15B). Moreover, 
similar to IP3R2, LPS (1 µg/ml) induced a transient increase in Ets1 transcript level 
within 1h in akt2
+/+
 DCs, but not in akt2
-/-
 DCs. Accordingly, the protein abundance 
of ETS1 in LPS-matured akt2
-/-
 DCs was significantly decreased (Fig. 15C). 
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Figure 15. Transcript level and protein abundance of the transcriptional factor 
Ets1 in akt2+/+ and akt2-/- DCs. 
A. The lysates of immature and LPS (1 µg/ml, 24h)-matured akt2+/+ and akt2-/- DCs 
were immunoprecipitated with a phosphospecific antibody that detects the 
consensus Akt phosphorylation sequence (RXRXX(S/T)) and then immunoblotted 
with IP3R2 antibody. 
B. Arithmetic means (± SEM, n=6) of the abundance of mRNA encoding Ets1 in 
immature akt2+/+ and akt2-/- DCs, as assessed by real-time PCR using Tbp mRNA as 
a reference gene. *(p<0.05), two-tailed unpaired t-test. 
C. Arithmetic means (± SEM, n=6-9) of the abundance of mRNA encoding Ets1 in 
akt2+/+ and akt2-/- DCs, unstimulated (LPS, 0h) and stimulated with LPS (1 µg/ml, 
1h and 4h) as assessed by real-time PCR using TbpP mRNA as a reference gene. 
**(p<0.01), ANOVA. 
D. Original representative Western blot of whole cell lysate protein of ETS1 (upper 
panel) and GAPDH (lower panel) in LPS (1 µg/ml, 24 h)-matured akt2+/+ and akt2-/-  
DCs.   
E. Arithmetic means ± SEM (n =6) of ETS1/GAPDH ratio in immature and LPS (1 
µg/ml, 24 h)-matured akt2+/+ and akt2-/- DCs. **(p<0.01), ANOVA. 
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3.9 Silencing of Ets1 Impaires the IP3R2 Transcript 
Abundance upon LPS Stimulation 
In order to test whether Akt2-dependent Ets1 expression can underlie decreased IP3R 
expression and function in akt2
-/- 
DCs, we performed silencing of Ets1 with siRNA (Fig. 16-
19). The efficiency of silencing assessed with RT-PCR was 47 ± 11% (n=7) and it was 
confirmed by western blotting (Fig. 16A). Upon LPS stimulation (1h), Ets1 and IP3R2 
transcript abundance were reduced in siEts1 DCs (Fig. 16B).  
 
Figure 16. Silencing of the Transcriptional Factor Ets1 Reduces IP3R2 Transcript 
Abundance upon 1H-LPS Treatment 
A. Western blot analysis of whole cell lysate protein of ETS1 in immature control 
(control siRNA) and siEts1-DCs. Representative experiments showing ETS1 band 
and GAPDH as loading control (left).  
B. Arithmetic means (± SEM) of the abundance of mRNA encoding Ets1 (n=14, left) 
and IP3R2 (n=7, right) in LPS (1 mg/ml, 24 1 h)-matured control (control siRNA) 
and siETS1 DCs, as assessed by real-time PCR using Tbp mRNA as a reference gene. 
* (p<0.05), two-tailed unpaired t-test.  
3.10 Silencing of Ets1 in LPS-matured DCs Reduces Ca
2+
 
Release and SOCE 
Moreover, thapsigargin-induced (Fig. 17A, B) and ATP-induced (Fig. 17C, D) Ca
2+
 release, 
thapsigargin-induced SOCE (Fig. 17A, B) were significantly impaired in siEts1 LPS (24 h)-
matured DC.  
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Figure 17. Silencing of the transcriptional factor Ets1 in LPS-matured akt2+/+ DCs 
reduces Ca2+ release, store-operated Ca2+ Entry. 
A. Representative tracing showing the Fura-2 fluorescence ratio in LPS (1 µg/ml, 
24 h)-matured control (control siRNA) and siEts1-DCs prior to and during exposure 
to thapsigargin (1 µM) in the Ca2+-free bath solution followed by readdition of 
extracellular Ca2+.  
B. Arithmetic means (± SEM) of the slope (right) and the peak (left) of the change 
in Fura-2 fluorescence following addition of thapsigargin (1 µM) in the absence 
(upper bars) and in the presence (lower bars) of extracellular Ca2+ to LPS (1 mg/ml, 
24 h)-matured control (n=55, open bars) and siEts1 (n=103, closed bars) DCs. 
**(p<0.01), *** (p<0.001), two-tailed unpaired t-test. 
C. Representative tracing showing the Fura-2 fluorescence ratio in LPS (1 µg/ml, 
24 h)-matured control (control siRNA) and siEtsTS1-DCs prior to and following 
addition of ATP (100 µM) to the Ca2+-free bath solution. 
D. Arithmetic means (± SEM) of the slope (right) and the peak (left) of the change 
in Fura-2 fluorescence following addition of ATP (100 µM) in the absence of 
extracellular Ca2+ to LPS (1 µg/ml, 24h)-matured control (n=38, open bars) and 
siEtsTS1 (n=61, closed bars) DCs. *** (p<0.001), two-tailed unpaired t-test. 
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3.11 Silencing of Ets1 in LPS-matured DCs Reduces the 
ICRAC Activity 
Similarly, ICRAC (Fig. 18A, B) was significantly impaired in siEts1 LPS (24 h)-
matured DCs.   
 
Figure 18. Silencing of the transcriptional factor Ets1 in LPS-matured akt2+/+ DCs 
reduces ICRAC activity 
A. Mean current-voltage (I/V) relationships of currents activated by 40 µM IP3 
normalized to cell capacitance in LPS (1 µg/ml, 24 h)-matured control (n=20) and 
siEts1 (n=17) DCs. *** (p<0.001), two-tailed unpaired t-test.  
B. Mean whole-cell conductance of inward currents (± SEM) calculated by linear 
regression of I/V curves shown in (F) between -40 and 0 mV in mature control 
(n=20) and siEts1 (n=17) DCs. * (p<0.05), two-tailed unpaired t-test. 
3.12 Silencing of Ets1 in LPS-matured DCs Impaires 
Migration  
Moreover, CCL21-dependent migration was significantly decreased in siEts1- LPS 
(24 h)-matured DCs (Fig. 19). Those data strongly suggests that Akt2 upregulates 
Ets1 transcription leading to enhanced expression of IP3R2. Increased Ca
2+
 release, 
followed by increased store-operated Ca
2+
 entry underlie, at least partially, 
stimulating effect of Akt2 on DC migration. 
Figure 19. Silencing of the transcriptional factor Ets1 
in LPS-matured akt2+/+ DCs impaires migration  
Arithmetic means ± SEM (n =11) of CCL21 (25 ng/ml, 
4h)-induced migration in in LPS (1 µg/ml, 24h)-
matured control (control siRNA) and siEts1 DCs. * 
(p<0.05), two-tailed unpaired t-test. 
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Part2. Serum- and Glucocorticoid-inducible Kinase 1 SGK1 in the Regulation of 
Dendritic Cell Functions 
3.13  SGK1 Deficiency Fosters DC Differentiation and 
Maturation 
For activation and maturation mouse DCs obtained from bone marrow were cultured 
with or without LPS (100 ng/ml, 48 h). Cells were collected and stained for MHC 
class II, costimulatory molecule CD86 (Fig. 20A-D) and the adhesion molecule 
CD54 (ICAM-1), which mediates DC-T cell interaction (Fig. 20E-I). The basal level 
of CD86, MHC II and CD54 was higher on CD11c
+
 gated population obtained from 
SGK1 knockout mice (sgk1
-/-
), if compared to CD11c
+
-DCs from the wild-type 
littermates (sgk1
+/+
) (Fig. 20C,D,F). Also stimulation by LPS led to higher receptor 
abundance in sgk1
-/- 
cells (Fig. 20C,D,I), suggesting that SGK1 down-regulates 
differentiation and maturation of DCs. 
Moreover, we isolated DCs from the spleen of sgk1
-/-
 and sgk1
+/+
 mice. Expression of CD86, 
MHCII and CD54 was higher in splenic sgk1
-/- 
DCs than in splenic sgk1
+/+
 DCs (Fig. 21), 
confirming our observations with bone marrow-derived cells. 
3.14 Phagocytic Capacity of sgk1
-/-
 DCs is Impaired 
The function of DCs as innate immune effectors involves antigen uptake. PI3K is 
known to play an important role for phagocytic uptake in DCs (Agrawal, Agrawal et 
al. 2007). Thus we compared the capacity of sgk1
+/+
 and sgk1
-/-
 DCs to phagocytose 
antigen by coincubating DCs with FITC-dextran. The phagocytosis of FITC-dextran 
was found to be significantly reduced in sgk1
-/-
 DCs (Fig. 22). 
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Figure 20. Differentiation and maturation of bone marrow derived DCs from 
sgk1+/+ and sgk1-/- mice 
A., B. Original dot plots of CD11c+CD86high (A) and CD11c+MHC II high (B) DCs at the 
basal level (control, 1st and 2d panels) and stimulated with LPS (100 ng/ml, 48 h, 3d 
and 4th panels) from sgk1+/+ (1st and 3d panels) and sgk1-/- (2d and 4th panels) mice. 
Numbers depict the percent of cells in the respective quadrants. 
C., D. Arithmetic means ± SEM (n = 4-5) of the percentage of CD11c+CD86+ (C) and 
CD11c+MHC II+ (D) DCs under control and 24 h after LPS stimulation in primary 
cultures from sgk1+/+ (closed bars) and sgk1-/-  (open bars) mice. * (p<0.05) and *** 
(p<0.001) indicate significant difference between sgk1+/+ and sgk1-/- cells (two-
tailed unpaired t-test). 
E., G. Representative FACS histograms depicting the expression of CD54 in control 
(E) and LPS-stimulated (100 ng/ml, 48 h, G) sgk1+/+ (grey line) and sgk1-/- (black 
line) cells. 
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F., I. Arithmetic means ± SEM (n = 9) of fluorescence intensity (MFI) of the CD54 
marker in control (F) and LPS-stimulated (100 ng/ml, 48 h, I) sgk1+/+ (closed bars) 
and sgk1-/- (open bars) cells. ** (p<0.01) and *** (p<0.001) indicate significant 
difference between sgk1+/+ and sgk1-/- cells (two-tailed unpaired t-test). 
 
 
 
Figure 21. Maturation status of splenic DCs from sgk1+/+ and sgk1-/- mice 
A., B. Original dot plots of CD11c+CD86+ (A) and CD11c+MHC II+ (B) splenic DCs 
from sgk1+/+ and sgk1-/- mice. Numbers depict the percent of cells in the 
respective quadrants, acquired within the dead cell gate. 
C., D. Arithmetic means ± SEM (n = 3-4) of the percentage of CD11c+CD86+ (C) and 
CD11c+MHC II+ (D) splenic DCs from sgk1+/+ (open bars) and sgk1-/- (closed bars) 
mice. *** (p<0.001) indicates significant difference between sgk1+/+ and sgk1-/- 
cells (two-tailed unpaired t-test). 
E. Representative FACS histograms depicting the expression of CD54 in sgk1+/+ 
(grey line) and sgk1-/- (black line) cells. 
F. Arithmetic means ± SEM (n = 4) of fluorescence intensity (MFI) of the CD54 
marker in sgk1+/+ (open bars) and sgk1-/- (closed bars) cells. ** (p<0.01) indicates 
significant difference between sgk1+/+ and sgk1-/- cells (two-tailed unpaired t-test). 
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Figure 22. Phagocytic capacity is impaired in sgk1-/- DCs 
A. Histogram representing the DCs percentage of the uptake of FITC-dextran after 
3h by sgk+/+ and sgk1-/- DCs. 
B. Arithmetic means ± SEM (n = 6) of FITC-dextran uptake by sgk+/+ (open bars) 
and sgk1-/- (closed bars) DCs. *** (p<0.001) indicates significant difference (two-
tailed unpaired t-test). 
3.15 sgk1
-/-
 DC Secrete Higher Levels of IL-12 in Response 
to LPS 
We next examined IL-12 production by sgk1
-/- 
DCs to determine the involvement of 
SGK1 signalling in DC cytokine production. DCs were stimulated with LPS (100 
ng/ml, 48 h) and IL-12p70 release was analyzed. sgk1
-/- 
DCs produced significantly 
higher amounts of IL-12p70 than sgk1
+/+
 DCs (Fig. 23A). No significant difference 
was observed in the production of IL-10, IL-6 and TNF-α (Fig. 23B-D). 
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Figure 23. IL-12 secretion is enhanced in sgk1-/- DCs 
Arithmetic means ± SEM (n = 18) of IL-12, IL-6, TNFα and IL-10 secretion in 
cultured sgk1-/- DCs (closed bars) and their wild-type littermates sgk1+/+ (open 
bars) under control conditions (control) and after stimulation with LPS (100 ng/ml, 
48h). ** indicates significant difference from LPS-stimulated sgk1+/+ cells (p<0.01; 
ANOVA). 
3.16 Loss of SGK1 Has No Effect on GSK3 
Phosphorylation 
Glycogen synthase kinase 3 (GSK3) has been demonstrated as a downstream target of 
PI3K, which mediates its inhibiting action on IL-12 production in DCs (Ohtani, Nagai, 
Kondo, Mizuno, Nakamura, Tanabe, Takeuchi, Matsuda, and Koyasu, 2008;Martin, 
Rehani et al., 2005;Zhang, Katz et al., 2009). We, therefore, studied GSK3 expression 
and LPS-induced phosphorylation in sgk1
+/+
 and sgk1
-/-
 DCs. As shown in Fig. 24, 
GSK3 is similarly expressed in DCs of both genotypes and LPS treatment similarly 
enhanced GSK3 phosphorylation in sgk1
+/+
 and in sgk1
-/-
 DCs (Fig. 24). 
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Figure 24. GSK3 phosphorylation is normal in sgk1-/- DCs 
A. Original western blot of the expression of phosphorylated GSK3 protein (upper 
panel), of total GSK3 protein (middle panel), and of GAPDH protein (lower panel) 
in sgk1+/+ and sgk1-/- DCs prior to (control) and 1h following addition of LPS (1 
µg/ml). 
B. Arithmetic means ± SEM (n=3-4 independent experiments) of phosphorylated 
over total GSK3 protein abundance in sgk1+/+ (open bars) and sgk1-/- (closed bars) 
DCs prior to (control) and 1h following addition of LPS.  
3.17 Loss of SGK1 Leads to Upregulation of NF-κB 
The NF-κB family of transcription factors plays a major role in regulating DC 
development, maturation and function (Li and Verma 2002). To gain further insights 
into the mechanisms responsible for enhanced APC functions of sgk1
-/- 
DCs, we 
analyzed p65 nuclear localization in sgk1
+/+
 and sgk1
-/-
 DCs by western blot of 
nuclear fraction. Already before stimulation, as well as upon stimulation with LPS 
(1µg/ml, 10 min) the nuclear localization of p65 was strongly enhanced in sgk1
-/-
 
DCs (Fig. 25). 
 
Figure 25. Loss of SGK1 enhances p65 nuclear localization in mouse DCs 
Original Western blot of nuclear p65 from sgk1+/+ and sgk1-/- DCs, which were 
either stimulated with LPS (1 µg/ml, 10 min) or left untreated (control). Protein 
loading was controlled by anti-Lamin A antibody.  
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3.18 Loss of SGK1 Results in Reduced Phosphorylation of 
NDRG-1 
N-myc downstream regulated gene 1 (NDRG1) has been shown to attenuate NF-κB 
signalling (Hosoi, Izumi et al. 2009). Cells overexpressing NDRG1 demonstrate 
reduced nuclear translocation of p65 (Hosoi, Izumi et al. 2009). Moreover, NDRG1 
is a physiological target of SGK1, phoshorylated by SGK1 at Thr328, Ser330 and 
Thr346 (Murray, Campbell et al. 2004). On the other hand, phosphorylation of 
NDRG1 at both Ser330 and Thr346 is required for its suppressive action on the NF-
kappaB signaling pathway (Murakami, Hosoi et al. 2010). Accordingly we analyzed 
NDRG1 expression and phosphorylation in unstimulated and LPS-stimulated sgk1
+/+
 
and sgk1
-/-
 DCs. As shown in Fig.26, SGK1-dependent phosphorylation of Thr346 
and Ser330 of NDRG-1 was decreased in unstimulated as well as in LPS (1h)-
stimulated sgk1
-/-
 DCs. 
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Figure 26. Phosphorylation of NDRG-1 is reduced in sgk1-/- DCs 
A. Original Western blot of sgk1+/+ and sgk1-/- DCs untreated (control) or 
stimulated with LPS (1 µg/ml, 1h). Protein extracts were analyzed by direct 
Western blotting using antibodies directed against phospho (p)-NDRG1 at Thr346 
(p-(Thr346)-NDRG1) and at Ser330 (p-(Ser330)-NDRG1). Equal protein loading was 
confirmed with GAPDH antibody. 
B. Arithmetic means ± SEM (n =5) of p-(Thr346)-NDRG1/GAPDH and p-(Ser330)-
NDRG1/GAPDH ratio in untreated and LPS (1 µg/ml, 1h)-treatedd sgk1+/+ (open 
bars) and sgk1-/- (closed bars) DCs. * (p<0.05), ** (p<0.01), ANOVA. 
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3.19 Knockdown of NDRG1 Results in Enhanced p65 
Nuclear Localization  
To prove the hypothesis, that diminished phosphorylation of NDRG-1 in sgk1
-/-
 DCs 
may underline enhanced localization of p65 in the nuclei of those cells, we silenced 
Ndrg1 by siRNA in sgk1
+/+
 DCs. This led to an enhanced nuclear abundance of p65 
compared to the control empty vector-treated DCs (Fig. 27). 
 
 
Figure 27. Enhanced nuclear localization of p65 upon NDRG1 knock-down in 
sgk1+/+ DCs 
Western blot analysis of nuclear p65 in untreated or LPS (1 µg/ml, 1h)-stimulated 
empty vector-transfected and siNDRG1-DCs. Representative experiments showing 
p65 band and Lamin-A as loading control. 
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4. Discussion 
In the first part of the present study we demonstrate that Akt2 is required for the 
expression of IP3R2 in mouse DCs and accordingly release of Ca
2+
 from intracellular 
stores and, as a consequence, store-operated Ca
2+
 entry and activation of Ca
2+
 
release-activated Ca
2+
 (CRAC) channels are diminished in Akt2 deficient DCs. 
Moreover, we provide evidence that IP3R2 expression in DCs is regulated by the 
Akt-2-dependent transcription factor ETS-1. Finally, we show that reduced IP3R2 
expression in Akt2-deficient DCs may underlie their defective migration.  
IP3R2 protein is similarly expressed in immature nonstimulated akt2
+/+
 and akt2
-/-
 
DCs. However, upon LPS-induced stimulation, the transcript abundance of IP3R2 is 
transiently enhanced in akt2
+/+
 but not in akt2
-/- 
DCs, and accordingly the expression 
of IP3R2 protein is higher in fully mature akt2
+/+
 compared to akt2
-/- 
DCs. Reduction 
in IP3R2 expression is paralleled by impaired function of IP3Rs in mature akt2
-/-
 DCs, 
as demonstrated by reduced Ca
2+
 release induced by P2Y receptor engagement or by 
inhibition of sarcoendoplasmatic reticulum Ca
2+
 ATPase (SERCA) with thapsigargin. 
Consequently, store-operated Ca
2+
 entry as well as IP3-induced activation of CRAC 
channels is diminished in Akt2-deficient DCs. Most importantly, increase of 
cytosolic free Ca
2+
 concentration upon ligation of the CCR7 is strongly reduced in 
mature akt2
-/-
 DCs, which is paralleled by a reduced CCR7-dependent migration of 
those cells. CCR7-dependent migration was very sensitive to the IP3R inhibitor 
Xestospongin C, and no difference in migrating ability could be detected between 
Xestospongin C-treated akt2
+/+
 and akt2
-/-
 DCs. This allows us to conclude that 
reduced expression of IP3R2 underlies, at least partially, the defective CCR7-
dependent migration of Akt2-deficient DCs. Akt2 knockdown has been similarly 
shown to result in reduced plasmin-triggered migration of human DCs (Li, Syrovets 
et al. 2010), and CSF-1- and MCP-1-induced chemotaxis of mouse peritoneal 
macrophages (Zhang, Ma et al. 2009).  
Akt2-dependent release of Ca
2+
 through the IP3R2 could be in line with the well-
established PI3K-dependent upregulation of Ca
2+
 mobilization in lymphocytes. 
Phosporylation of Akt/PKB is compromised and Ca
2+
 flux in response to anti-IgM 
crosslinking and to anti-CD3 crosslinking was attenuated in p110δ D910A/D910A 
mice, in accord with an important role for PI3Ks upstream of Tec family kinase–
mediated activation of phospholipase Cγ (PLCγ) and Ca2+ signalling by antigen 
receptorsCa
2+
 flux is attenuated in B and T lymphocytes deficient in the catalytic 
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subunit of PI3K, p110δ, in response to stimulation of B and T cell antigen receptors, 
respectively .(Okkenhaug, Bilancio et al. 2002). Diminished Ca
2+
 mobilization in B 
cells with either genetical or pharmacological inhibition of p110δ has been also 
confirmed in other studies (Inabe and Kurosaki 2002; Jou, Carpino et al. 2002; 
Bilancio, Okkenhaug et al. 2006). Jou showes in contrast to the absence of detectable 
Ca
2+
 mobilization in PLCγ2-/-  B cells, p110δ-/- B cells induce an increase in 
intracellular Ca
2+
 that is approximately 25% of that observed in wild-type cells. In 
addition, mobilization of intracellular Ca
2+
 upon anti-CD3 stimulation is unimpaired 
in p110δ-/- T cells. The study of Bilancio in primary splenic B cells, demonstrates the 
PI3K-dependent fraction of early intracellular Ca
2+
 flux is also completely dependent 
on p110δ catalytic activity. They suggest that most likely, these functions of p110δ 
derive from the stimulatory effects of its PIP3 lipid product on the activation of 
phospholipase C80 (leading to the generation of diacylglycerol and IP3, which 
induces the release of intracellular Ca
2+
) and on PDK1. Again, such a key role for 
p110 is remarkable given the high level of residual class IA PI3K activity in p110δ 
D910A/D910A cells. Whether Akt-dependent upregualtion of IP3R plays a role in 
those cells needs to be established. However, one study on DT40 B cells and Jurkat 
cells reports an inhibiting effect of Akt2 on Ca
2+
 mobilization (Martin, Wang et al. 
2012). Whereas the initial amplitude of Ca
2+
 mobilization has not been influenced by 
Akt2, the subsequent clearance of Ca
2+
 is enhanced by Akt2, which results in a 
reduced duration of Ca
2+
 increase paralleled by a reduced activation of NFAT 
(Martin, Wang et al. 2012). The mechanism of Akt2-dependent reduction of Ca
2+
 
mobilization proposed by Martin et al. involves Akt2 interaction with Bcl-2 proteins, 
which bind to IP3R to inhibit Ca
2+
 release (Martin, Wang et al. 2012). Accordingly 
the cell permeable peptide that blocks the interaction between Bcl-2 and IP3R 
abrogates the effect of Akt2 (Martin, Wang et al. 2012). However, enhanced Ca
2+
 
clearance rather than modified Ca
2+
 release measured in the presence of Akt2 may 
also indicate Akt2-dependent upregulation of SERCA or any other extrusion 
pathways in this model. 
Several mechanisms of Akt-dependent regulation of IP3Rs have been detected so far. 
A direct interaction and phosphorylation of IP3R by Akt has been demonstrated 
(Khan, Wagner et al. 2006; Varga-Szabo, Authi et al. 2008). Szado et al. have shown 
that Akt-dependent phosphorylation of IP3Rs significantly reduces their Ca
2+ 
release 
activity (Varga-Szabo, Authi et al. 2008), however another study of Khan et al. has 
not revealed any modification of IP3R function by Akt phosphorylation (Khan, 
Wagner Ii et al. 2006). We could detect phosphorylation of IP3R2 at the Akt specific 
motif, however no difference in phosphorylated IP3R2 was observed between akt2
-/-
 
and akt2
+/+
 DCs. Another proposed mechanism involves Akt-dependent regulation of 
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Bcl-2 anti-apoptotic proteins (Martin, Wang et al. 2012), which are known to interact 
with IP3R through their anti-apoptotic BH4 domain and inhibit Ca
2+
 release (Rong, 
Bultynck et al. 2009). The present study provides another novel mechanism of Akt2- 
and ETS1-dependent transcription of IP3R2. 
ETS1 is a transcription factor highly conserved throughout evolution, highly 
expressed in lymphocytes and in tumors (Garrett-Sinha 2013). Ets1 seems to mediate 
the upregulating effect of Akt2 on IP3R2 expression in mouse DCs. The kinetics of 
Ets1 transcription upon LPS stimulation follows the same pattern as IP3R2 with a 
rapid and transient upregulation of Ets1 transcript abundance after 1h treatment with 
LPS, and although the ETS1 protein level is not increased in fully mature compared 
to immature akt2
+/+
 DCs, mature akt2
-/-
 DCs expressed significantly less ETS1 
protein than mature akt2
+/+
 DCs. Moreover, IP3R2 expression is strongly reduced 
upon Ets1 knock down. Silencing of Ets1 resulted in a strong impairement of Ca
2+
 
release induced either by inhitibition of SERCA with thapsigargin or by ligation of 
P2Y receptors with ATP. These results are in accordance to the study on ETS1 
deficient CD4 T cells in which Ca
2+
 mobilization in response to TCR ligation is 
impaired (Nagaleekar, Diehl et al. 2008). Moreover, IP3R3 has clearly been shown to 
be under transcriptional regulation by Ets1 (Tamura, Hashimoto et al. 2001; 
Nagaleekar, Diehl et al. 2008).  
Ets1 gene expression is known to be stimulated by activated Akt (Lavenburg, Ivey et 
al. 2003; Ghosh, Basu et al. 2012; Smith, Findlay et al. 2012). In prostate cancer cells 
elevated Akt (v-akt murine thymoma viral oncogene homolog) activity has been 
demonstrated to increase ETS1 protein levels and exogenous ETS1 expression is 
sufficient to rescue invasive potential decreased by inhibition of Akt activity (Smith, 
Findlay et al. 2012). On the other hand, inhibition of PI3k/Akt pathway blocks 
transcriptional upregulation of Ets1 by ER stress in human melanoma cells (Dong, 
Jiang et al. 2011) and by PDGF in human aortic vascular smooth muscle cells (Lang, 
Artunc et al. 2009). Moreover, knockdown of Akt3 reduced the basal levels of ETS1 
in melanoma cells, suggesting that the PI3k/Akt pathway may have a role in 
regulating constitutive expression of Ets-1 (Dong, Jiang et al. 2011). Expression of 
ETS1 was reduced in akt2
-/-
 DCs only upon stimulation with LPS. LPS has been 
shown to trigger PI3K stimulation with the consequent Akt phosphorylation in 
mouse DCs (Fukao, Tanabe et al. 2002; Fukao and Koyasu 2003). Thus, LPS-
induced activation of Akt2 is probably required for the continuous expression of 
ETS1 upon DC maturation. 
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In conclusion, Akt2 upregulates IP3R2 transcription in DCs, presumably by 
enhancing the expression of ETS1 and this effect may underlie the stimulating effect 
of Akt2 on DC migration. 
Similar to PKB/Akt, SGK1 is activated through PI3K and phosphoinositide-
dependent kinase PDK1 (Alessi, Andjelkovic et al. 1996; Kobayashi, Deak et al. 
1999; Park, Leong et al. 1999). Recent studies indicate that PI3K and PDK1 may 
function as an endogenous negative feedback that serves to limit excessive innate 
immune responses (Fukao and Koyasu 2003; Zaru, Mollahan et al. 2008). SGK1 could 
act downstream of PI3K and PDK1 to mediate this negative feedback in DCs. 
The second part of the present study reveals that in contrast to Akt2-deficiency, lack of 
SGK1 substantially influences maturation and function of DCs. Accordingly, 
expression of maturation markers and secretion of IL-12 upon LPS stimulation were 
enhanced and phagocytic capacity was decreased in bone marrow DCs from gene 
targeted mice lacking functional SGK1 (sgk1
-/-
) as compared to DCs from wild type 
littermates (sgk1
+/+
). The differences in genotypes were paralleled by reduced 
phosphorylation of NDRG-1 and enhanced nuclear translocation of NF-κB in sgk1-/- 
DCs. Silencing of NDRG-1 in sgk1
+/+
 DCs increased nuclear NF-κB abundance. The 
present observations thus disclose SGK1 as a new major player controlling DC 
maturation and provide the mechanism of SGK1- and NDRG-1-dependent NF-κB 
regulation.  
SGK1 seems to be important for development and maturation of DCs since the 
expression of CD86, CD54 and MHC class II molecules is higher in sgk1
-/- 
cells. 
Immature DCs are characterized by a high rate of endocytosis, which rapidly 
decreases during maturation (Banchereau, Briere et al. 2000; Granucci, Zanoni et al. 
2003). Thus, in accordance to higher expression of maturation markers, sgk1
-/-
 DCs 
exhibit reduced phagocytic capacity. This is in agreement with a study on human 
DCs, showing that pharmacological inhibition of PI3K in DCs results in decreased 
phagocytosis (Agrawal, Agrawal et al. 2007). 
In DCs, monocytes and macrophages, PI3K activation suppresses production of 
inflammatory cytokines, such as IL-12, triggered by TLR signaling (Fukao, Tanabe 
et al. 2002; Guha and Mackman 2002; Fukao and Koyasu 2003; Goodridge, Harnett 
et al. 2003; Fang, Pengal et al. 2004; Aksoy, Vanden Berghe et al. 2005; Kuo, Lin et 
al. 2006; Jackson, Mulcahy et al. 2010). The present study shows that loss of SGK1 
results in a higher level of IL-12 secretion by LPS-stimulated DCs, suggesting that 
SGK1 may be a key player downstream from PI3K and PDK1 preventing excessive 
IL-12 production. 
The nuclear factor-κB (NF-κB)/REL family of transcription factors plays a central role 
in coordinating the expression of a wide variety of genes that control immune responses 
(Ardeshna, Pizzey et al. 2000; Li and Verma 2002). PI3K has been shown to negatively 
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regulate NF-κB in human monocyte-derived DCs (Aksoy, Vanden Berghe et al. 2005), 
human monocytes (Guha and Mackman 2002; Martin, Schifferle et al. 2003) and 
mouse macrophages (Fang, Pengal et al. 2004). Thus, PI3K inhibitors increased IκB 
kinase (IKK)-α/β phosphorylation and IκB-α degradation with a concomitant increase 
in NF-κB nuclear translocation upon TLR3 or TLR4 engagement in human DCs 
(Aksoy, Vanden Berghe et al. 2005). Inhibition of the PI3K pathway enhanced LPS-
induced TNF-α and TF gene expression via increased activation of transcriptional 
factors Egr-1, AP-1 and NF-κB in human monocytes (Guha and Mackman 2002). In 
Porphyromonas gingivalis LPS-stimulated human monocytes, inhibition of PI3K 
resulted in the augmentation of NF-κB p65 activation (Martin, Schifferle et al. 2003). 
Our data showing enhanced NF-κB nuclear localization in sgk1-/- DCs provide evidence 
that SGK1 is involved in the suppressive effect of PI3K on NF-κB in DCs. 
A specific substrate of SGK1, NDRG-1 (N-myc downstream regulated gene 1), which 
is phosphorylated by SGK1 (and not by Akt) at three different sites (Murray, 
Campbell et al. 2004), has been shown to attenuate NF-κB signalling (Hosoi, Izumi 
et al. 2009), when phosphorylated at two SGK1-dependent sites (Ser330 and Thr346) 
(Murakami, Hosoi et al. 2010). Phopshorylation at Ser330 and Thr346 was strongly 
reduced in sgk1
-/-
 DCs. Moreover, silencing of NDRG-1 in sgk1
+/+
 DCs led to 
enhanced nuclear localization of the NF-κB. Therefore, SGK1 may prevent transport 
of NF-κB to the nucleus via phosphorylation of NDRG-1. 
In contrast to studies showing that the PI3K pathway negatively regulates expression of 
inflammatory genes in macrophages and DCs, the PI3K pathway positively regulates 
NF-κB activity and NF-κB-dependent gene expression in other cell types. Thus, in 
airway epithelial cells the PI3K-Akt positively regulate NF-κB transcriptional 
activity (Thomas, Monick et al. 2002). In 3T3 fibroblasts, overexpression of a 
constitutively active form of Akt results in NF-κB-dependent gene expression via the 
activation of IKK and the p38 MAPK (Madrid, Mayo et al. 2001). SGK1 has been 
shown to phosphorylate IKKβ (Zhang, Cui et al. 2005) or IKKα (Tai, Su et al. 2009) 
and thus to promote the degradation of IκB. Moreover, SGK1 increases the acetylation 
of NF-κB through phosphorylation of p300, which also leads to NF-κB activation(Tai, 
Su et al. 2009). SGK1 is a positive regulator of NF-κB in mast cells (Eylenstein, 
Gehring et al. 2012) and megakaryocytes (Borst, Schmidt et al. 2012). Moreover, SGK1 
is required for the stimulation and nuclear translocation of NF-κB following 
mineralocorticoid excess (Vallon, Wyatt et al. 2006; Terada, Ueda et al. 2012) and 
thrombin (BelAiba, Djordjevic et al. 2006). Thus, it is possible that the effect of PI3K 
pathway in general and SGK1 in particular on NF-κB is dependent on the presence of 
one or more cell type-specific co-factors.  
Interestingly, DCs lacking SGK1, as well as DCs treated with PI3K inhibitors carry the 
same functional defects as DCs obtained from elderly humans (Agrawal, Agrawal et al. 
2007). DCs from aging individuals are similarly less efficient in phagocytic uptake 
and have increased secretion of cytokines than the younger counterparts (Agrawal, 
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Agrawal et al. 2007). In elderly subjects decreased phosphorylation of Akt was 
observed in LPS-stimulated DCs. Possibly, SGK1 participates in the modification of 
DCs during ageing. 
SGK1 is under strong genomic stimulation by glucocorticoids (Firestone, Giampaolo 
et al. 2003) and 1,25-dyhydroxyvitamin D3 (Akutsu, Lin et al. 2001). Given that both 
hormones have strong inhibitory effect on DC functions (Yamaguchi, Tsumura et al. 
1997; Etten and Mathieu 2005; Lyakh, Sanford et al. 2005; Griffin, Dong et al. 2007; 
Penna, Amuchastegui et al. 2007; Shumilina, Xuan et al. 2010; Heise, Shumilina et 
al. 2011), it is intriguing to speculate that their mechanism of action in DCs might 
include SGK1 activation. 
In conclusion, genetic knockout of SGK1 leads to profound changes in DC functions, 
including changes in maturation, phagocytic capacity and cytokine production. 
Moreover, at least some of these effects seem to be mediated through the reduced 
phosphorylation of NDRG-1 and enhanced nuclear localization of the transcription 
factor NF-κB. 
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